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Abstract 
 
Background: There are approximately 900,000 people in the United Kingdom living 
with heart failure (HF). Adhering to the treatment regime for HF can be challenging. 
Non-adherence is common in relation to taking medication, following a suggested diet 
plan, and a failure to seek medical care when symptoms begin to escalate. These are 
all aspects related to self-care. Engaging is self-care behaviours may improve quality 
of life, medication adherence, reduce hospital admissions and reduce mortality.  
Aim: The current review attempted to identify and synthesise randomised controlled 
trials (RCTs) investigating interventions designed to try to improve self-care 
behaviours in people with HF. 
Methods: Nine computerised databases (Cochrane Library, OVID Medline, OVID 
Embase, EBSCO CINAHL, EBSCO Psychinfo, EBSCO Psycharticles, EBSCO 
Psychology and Behavioral Sciences Collection, Web of Science and Google Scholar) 
were searched from the start date of the respective database to 4
th
 January 2018. 
Results: Thirteen RCTs met inclusion criteria and were assessed to determine their 
risk of bias. Eleven of these studies involved an education and skills building 
programme, led by nursing staff either via telemonitoring, outpatient visits, home 
visits, and/or telephone calls. Two studies involved developing participant specific 
goal-based outcomes, and supporting participants to achieve goals. The results 
suggest that people are more likely to engage in self-care behaviours when they get 
extra support and education from nursing staff than when they simply attend routine 
outpatient appointments. However, risk of bias was identified in all but one study, 
with 10 of the 13 studies being assessed as ‘High’ risk of bias.  
Application: Further research should aim to quantify the optimum length of input that 
people should receive following diagnosis of HF and discharge from hospital. Also, to 
determine the optimum number of home visits or telephone visits that people should 
receive. This area of research would also benefit from improvements in designing and 
reporting bias-reducing methods. 
Key words: Heart failure, self-care, randomised controlled trial 
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Introduction 
Heart failure (HF) occurs when the heart fails to pump blood around the body as 
effectively as it used to (The British Heart Foundation; BHF). According to the 
British Society for Heart Failure, there are approximately 900,000 people in the 
United Kingdom living with HF. It causes or complicates about 5% of all emergency 
admissions and it consumes approximately 2% of the total NHS expenditure (British 
Society for Heart Failure; 2013/2014 NHS standard contract). Most of the care 
required for people with HF is related to hospital readmissions as a result of 
exacerbations in HF symptoms. The main factors contributing to this are non-
adherence to a broad range of health behaviours including medication use and dietary 
control, and a failure to seek medical care when symptoms begin to escalate (Moser, 
Dickson, Jaarsma, Lee et al., 2012). These factors have been identified as components 
contributing to self-care (Harkness, Spaling, Currie, Strachan & Clark, 2015; Moser et 
al., 2012; Riegel, Moser, Anker et al., 2009).  
Self-care can be defined as a ‘rational process, involving purposeful choices and 
behaviours, reflecting knowledge and thought’ (Riegel & Dickson, 2008). It is a 
proactive process, involving compliance with professional advice, paying close 
attention to one’s body, and responding to symptoms appropriately. Self-care is 
considered essential in the management of chronic illness. Riegel and Dickson (2008) 
noted that for people with HF, repeated hospitalisations was attributed to poor self-
care. They developed a ‘Situation-Specific’ model of HF, which identifies three 
separate, but related processes that people must engage with for effective self-care 
management. The first process involves engaging in self-care maintenance 
behaviours, such as, medication management, following suggested diet and fluid 
restrictions, engaging in daily exercise and monitoring symptoms daily (Buck, 
Harkness, Wion, Carroll et al., 2015). The second process involves successfully 
detecting physical symptoms and interpreting what they mean. Finally, responding to 
the symptoms appropriately is the process of self-care management (Riegel et al., 
2016).  
Riegel and Dickson (2008) highlighted that engaging in these processes effectively is 
influenced by factors related to the person, the problem and the environment. For 
example, factors such as peoples’ experience or knowledge of the illness, the level of 
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social support they have, their attitudes, confidence, self-efficacy, the presence and 
severity of depression and anxiety and their physical functioning all influence the 
decisions people make regarding HF self-care (Harkness et al., 2015; Kessing, 
Denollet, Widdershoven & Kupper, 2016; Riegel, Lee & Dickson, 2011; Riegel et al., 
2016). Therefore the decision-making process of self-care management is dynamic 
and influenced by many factors, and may explain why people find mastering self-care 
to be challenging. 
The importance of supporting people to engage in these self-care behaviours is well 
recognised (Harkness et al., 2015; Riegel et al., 2016) and has been highlighted in 
guidelines across America and Europe in relation to treatment and management 
(Lindenfeld, Albert, Boehmer, et al., 2010; McKelvie, Moe, Ezekowitz, et al., 2012; 
McMurray, Adamopoulos, Anker, et al., 2012). Engaging in self-care behaviours has 
been shown to improve quality of life (QoL), improve medication adherence, reduce 
hospital visits and admissions and reduce mortality (Buck, Lee, Moser, Albert et al., 
2012; Jovicic, Holroyd-Leduc & Straus, 2006; Lee, Carlson, & Riegel, 2007; Wang, 
Lin, Lee & Wu, 2011; Zambroski, 2008).  
As mentioned, engaging in self-care behaviours can be challenging due to the 
personal, psychosocial and contextual factors that influence self-care (Riegel et al., 
2009; Harkness et al., 2015). Qualitative research has attempted to better understand 
self-care behaviours in people with HF. For example, qualitative studies have 
attempted to explore self-care needs, and the strategies that people use to 
accommodate self-care recommendations into their daily lives. A meta-synthesis of 
qualitative research literature conducted by Harkness et al., (2015) recommended that 
healthcare providers should aim to provide a person-centred and individualised 
approach, to help support and encourage self-care strategies and behaviours. It also 
highlighted the value of caregivers for providing support to people with HF and 
encourages health systems to include caregivers, wherever possible, when trying to 
implement strategies and education around self-care (Harkness et al., 2015). 
Quantitative studies have attempted to design interventions aimed at targeting key 
self-care behaviours. These studies have attempted to improve aspects of self-care 
behaviours known to be important for successful HF management. These studies are 
usually nurse-led interventions that involve educating people about their illness, and 
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providing guidance and advice to manage their treatment, and to monitor their 
symptoms. People are then monitored via home visits (HV), structured telephone 
support or telemonitoring (Buck et al., 2012; Clark, McDougall, Riegel, Joiner-
Rogers et al., 2015). For example, a systematic review and meta-analysis by Clark, 
Inglis, McAlister, Cleland et al. (2007) concluded that introducing a telemonitor into 
patients’ homes, to support them to monitor their symptoms, had a positive effect on 
clinical outcomes for people with chronic HF.  
Objectively measuring self-care can be challenging.  Self-care outcome measures 
attempt to measure change, or improvements in self-care behaviours, before and after 
an intervention. Two of the most common self-care outcome measures are the 
European Heart Failure Self-Care Behaviour Scale (EHFScB Scale) or the Self-Care 
of Heart Failure Index (SCHFI) (Buck et al., 2012; Riegel et al., 2009; Riegel et al., 
2011). Such measures are useful in determining the effectiveness of interventions.  
However, the author is unaware of any quantitative review that synthesises 
interventions aimed at improving self-care behaviours for people with HF and which 
monitor and measure self-care outcomes using validated self-care outcome measures. 
Therefore, the current review attempted to identify and synthesise studies 
investigating interventions designed to try to improve self-care behaviours in people 
with HF. There is an increasing quantitative literature that aims to improve self-care 
outcomes in people with HF, therefore it was decided that, due to practical limitations, 
the review would focus on the most rigorous quantitative method, randomised 
controlled trials (RCTs).  
Questions 
1. For people with a diagnosis of HF, what are the characteristics of interventions 
that have been designed to improve self-care outcomes? 
2. What is the effectiveness of these interventions at improving self-care 
outcomes? 
3. Do these interventions improve other aspects for people with HF, such as, 
quality of life, number of hospitalisations? 
Method 
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Search Strategy 
The following online databases were systematically searched for relevant articles: 
OVID Medline, OVID Embase, EBSCO CINAHL, EBSCO Psychinfo, EBSCO 
Psycharticles, EBSCO Psychology and Behavioral Sciences Collection, Web of 
Science and Google Scholar. The search was limited to randomised controlled trials 
(see Appendix 2 for search strategy to limit search to RCTs). The following search 
terms were used: “heart failure” OR “cardio-renal syndrome” OR “dyspnea, 
paroxysmal” OR “oedema, cardiac” OR “edema, cardiac” OR “heart failure, 
diastolic” OR “heart failure, systolic” AND “self-care” OR “self care” OR “self-
manag*” OR “self manag*”. Online titles and abstracts were reviewed and duplicates 
removed. Articles were then examined to determine if they met eligibility criteria. The 
full text of potentially eligible papers were obtained. Hand searches of review papers 
were also conducted to identify any eligible studies. The reference section of papers 
that were identified by the electronic database searches were inspected to identify 
additional studies to be included in the review. 
Inclusion and Exclusion Criteria 
Articles identified by the search strategy were screened using the following criteria: 
Inclusion criteria: 
 Journal article published in a peer reviewed journal  
 Written in English 
 Adults (aged 18 and above) 
 Diagnosis of heart failure 
 Methodology – RCTs only 
 Self-care measured by previously validated instruments 
Exclusion criteria: 
 Review articles, books, book chapters and conference papers.  
 Commentaries/descriptions, case studies/reports/unpublished theses/policy 
documents.  
 No data, preliminary data, or qualitative data. 
 Studies including family members/caregivers  
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Quality appraisal 
The Cochrane Risk of Bias Tool (Higgins Altman, Gotzsche & Juni, 2011; Lundh & 
Gøtzsche, 2008) was used to assess all eligible articles. Two assessors evaluated each 
article, assigning ‘low’, ‘high’ or ‘unclear’ risk of bias across all seven domains: 
random sequence generation, allocation concealment, blinding of participants and 
personnel, blinding of outcome assessment, incomplete outcome data, selective 
reporting, and other bias. Evidence of each was recorded and where disagreement 
occurred consensus was reached via discussion. Where a decision could not be 
reached a third person (research advisor) provided a final opinion. Based on Higgins 
et al. (2011), an overall risk of bias was determined for each study. If a study was 
rated as ‘High’ risk of bias in one of the seven domains, it was judged to be overall 
‘High’ risk of bias. 
 
Effect sizes 
Effect sizes were calculated to determine differences in self-care scores between the 
intervention and control groups at final data collection point. Differences in scores 
were calculated using ‘Cohen’s d’ equation (differences in means divided by pooled 
SD). Two studies (Clark et al., 2015; Shively et al., 2013) reported differences over 
time, however only Clark et al., 2015, included statistics. For this study, the effect size 
was calculated using the following equation:  
Fdfn > 1   
 
One study reported an effect size calculation (Creber et al., 2016). For some studies 
(Hoban et al., 2013, Clark et al., 2015, Creber et al., 2016; Shively et al., 2013) effect 
sizes could not be calculated due to a lack of data, or incomplete data. As a result, a 
meta-analysis could not be conducted. Authors were contacted via email to request 
additional data to enable effect sizes to be calculated.  
 
Results 
Figure 1 provides an overview of the search, screen and eligibility assessment process 
followed within this review. A total of 570 studies were identified from database 
searches excluding duplicates, a further 3 studies were identified via hand searches of 
the reference lists of key articles, giving a total of 573 studies. Of these, 193 
duplicates were extracted using a manual hand search. A further 350 were excluded 
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following a review of the article abstracts. Thirty full articles were subsequently 
assessed for eligibility and 17 further studies were excluded. A final total of 13 
articles were included for data extraction and evaluation. A hand search of the 
reference list of the 13 identified studies found no additional papers. Table 1 provides 
relevant details of study design and findings. The selection included international 
research from seven countries across four continents: Europe (2), North America (5), 
Asia (3), and South America (3). 
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Figure 1. PRISMA (2009) Flowchart of the article selection process 
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Participant characteristics 
A total of 2160 participants were included in the 13 studies. Of these, 844 (39%) were 
female and 1316 (61%) were male. The smallest sample size was 33 (Oliveria, 
Cordeiro, Rocha, Guimaraes et al., 2017) and largest sample size was 602 (Dracup, 
Moser, Pelter, Nesbitt et al., 2014). The mean age of participants was 61.3 years (60.0 
– 80.6). Seven studies recruited patients from hospital following HF-related 
hospitalisation (Creber, Patey, Lee, Kuan et al., 2016; Hagglund, Lynga, Frie, Ullman 
et al., 2015; Mussi, Ruschel, Souza, Lopes et al., 2013; Oliveria et al., 2017; Rahmani, 
Moradi, Aghakarimi & Hossain-Gholipour, 2017; Souza, Rohde, Ruschel, Mussi et 
al., 2014; Yu, Lee, Stewart, Thompson et al., 2015). Three studies recruited from 
outpatient units (Boyne, Vrijhoef, Spreeuwenberg, De Weerd et al., 2014; Sezgin, 
Mert, Ozpelit & Akdeniz, 2017; Shively, Gardetto, Kodiath, Kelly et al., 2013). 
Finally, three studies recruited from a mixture of outpatient clinics, hospitals, media, 
senior centres and assisted living facilities (Clark, McDougall, Riegel, Joiner-Rogers 
et al., 2015; Dracup et al., 2014; Hoban, Fedor, Reeder & Chernick, 2013).  
 
The primary diagnosis for inclusion in the studies was HF, clarified by the studies as a 
formal clinical diagnosis of HF such as Acute Decompensated HF (ADHF), HF stage-
C, Heart Failure reduced Ejection Fraction (HFrEF) or Heart Failure with preserved 
Ejection Fraction (HRpEF). Seven studies used the New York Heart Association 
(NYHA) functional classification system to identify the diagnosis. Comorbidities 
were reported by six studies. The most common comorbidities were: hypertension, 
diabetes, Chronic Obstructive Pulmonary Disease (COPD), renal disease, depression 
and chronic pain (Creber et al., 2016; Dracup et al., 2014; Hagglund et al., 2015; 
Mussi et al., 2013; Oliveria et al., 2017; Yu et al., 2015). Seven of the studies did not 
report whether the participants had any comorbidities (Boyne et al., 2014; Clark et al., 
2015; Hoban et al., 2013; Rahmani et al., 2017; Sezgin et al., 2017; Shively et al., 
2013; Souza et al., 2014). 
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Table 1: Characteristics and findings of studies 
Author 
(country) 
Sample Control 
group 
Intervention  
Group 
Self care measures 
and timeline 
Other 
measures 
Main Self-Care Finding and  
Cohen’s d 
Boyne et al., 
2014 
 
(The 
Netherlands) 
382 
randomised 
(156 females 
226 males) 
 
Intervention 
n =197 
(mean age = 
71.0) 
 
Control = 
185 (mean 
age = 71.9) 
Usual 
medical 
care 
Telemonitoring 
device – pre-set 
dialogues and 
questions about 
symptoms, 
knowledge, 
behaviour. 
Educational/intensi
ve symptom 
monitoring 
programme 
followed. 
12-item EHFScB scale 
 
Data collected: 
Baseline, 3m, 6m, 12m 
Dutch HF 
knowledge 
Scale 
 
Barnason 
Efficacy 
Expectation 
Scale 
 
HF Compliance 
scale 
Significant difference at 12m:  
 
Intervention: M=17.4 (SD=4.5) 
 
Control: 
M=20.8 (SD=5.8) 
 
Cohen’s d = 0.66 
(Effect size calculated) 
Clark et al., 
2015 
 
(USA) 
50 
randomised 
(26 female 
24 male) 
 
Intervention: 
n = 25 (mean 
age = 61.7) 
 
Control: n = 
25 (mean age 
= 63.0) 
 
Usual 
medical 
care  
9-month 
intervention. 
1
st
 phase (3 
months): 
educational and 
skill building 
programme.  
2
nd
 phase (3 
months): telephone 
contact, no home 
visits.  
3
rd
 phase (3 
months) no home 
visits or telephone 
15-item SCHFI 
 
Baseline, 3m, 6m and 
9m 
KCCQ 
 
GDS 
 
Metamemory in 
Adulthood 
Questionnaire 
 
HFKT 
 
 
Self-care maintenance: difference 
non-significant 
 
Effect size d=0.40 
(Effect size calculated) 
 
Self-care confidence: Improvement 
significantly greater in intervention 
than control  (F = 6.70, df = 3, 43, p 
= .001)  
 
Effect size d=0.68. 
(Effect size calculated) 
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Author 
(country) 
Sample Control 
group 
Intervention  
Group 
Self care measures 
and timeline 
Other 
measures 
Main Self-Care Finding and  
Cohen’s d 
contact, patient 
required to 
communicate with 
physician if 
questions arose. 
Self-care management: scores over 
time not reported: time 3 only, mean 
rank reported  (intervention=12.22, 
Control=6.78)  
Mann Whitney U = 16.00, df = 1, p = 
.03. 
 
Creber et al., 
2016 
 
(USA) 
100 
randomised 
(20 females 
47 males) 
 
Intervention 
n = 41 (mean 
age = 60)  
 
Control n = 
26 (mean age 
= 63) 
 
Usual 
medical 
care.  
Motivational 
Interviewing 
programme: 
Identify at least 2 
specific goals, plan 
for accomplishing 
goals set out and 
reinforced in the 
follow-up calls. 
22-item SCHFI 
 
Baseline, 90 days 
 
 
HFSPS 
 
KCCQ 
Self-care maintenance: significant 
difference at end of intervention: 
 
Intervention: M=19.7 (SD=16.0) 
Control: M=12.1(SD=18.3) 
Cohen’s d=0.44 
(Reported in study) 
 
Self-care confidence: difference non 
significant (data not reported) 
 
Self-care management scores not 
reported 
 
Dracup et 
al., 2014 
 
(USA) 
602 
randomised 
(244 females 
358 males) 
 
Fluid 
watcher 
LITE: n = 
Routine 
care. Given 
educational 
brochures, 
healthcare 
logbooks. 
Fluid watchers 
LITE group – 
weight and HF 
symptoms diaries, 
educational session, 
medication, diet, 
self-monitoring, 
coaching. Two 
9-item EHFScB scale 
 
 
 
Baseline, 3m, 12m and 
24m 
Charlson 
Comorbidity 
Index 
 
HF knowledge 
Scale 
 
Short test of 
At 24m no sig difference between 
control group and intervention 
groups: 
 
Control group: M=23.15 (SE=0.54) 
 
Fluid LITE group: M=21.92 
(SE=0.56) 
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Author 
(country) 
Sample Control 
group 
Intervention  
Group 
Self care measures 
and timeline 
Other 
measures 
Main Self-Care Finding and  
Cohen’s d 
200 (mean 
age = 65.9) 
 
Fluid 
watcher 
PLUS: n = 
193 (mean 
age = 66.1) 
 
Control: n = 
209 (mean 
age = 66.4) 
phone calls at 2-
week intervals. 
 
Fluid watcher 
PLUS group – as 
above plus 
audiotape of 
education session 
and bi weekly 
follow up phone 
calls. 
Functional 
Health Literacy 
in Adults 
 
Hospitalisations 
 
Cohen’s d = 0.16  
(Effect size calculated) 
 
Fluid LITE plus group: M=21.85 
(SE=0.56) 
 
Cohen’s d = 0.16 
(Effect size calculated) 
 
 
 
 
Hagglund et 
al., 2015 
 
(Sweden) 
82 
randomised 
(26 female 
56 male) 
 
Intervention 
n = 32 (mean 
age = 75.0) 
 
Control n = 
40 (mean age 
= 76.0) 
Usual 
medical 
care. 
Home Intervention 
System (HIS). Info 
on weight, drug 
dose, lifestyle 
advice, contact 
details for info and 
support, and tips on 
how to improve 
living with HF.  
Patient could 
evaluate their own 
perceived health. 
9-item EHFScB scale 
 
Baseline, 3m 
HRQoL 
 
KCCQ 
 
SF-36 
 
Dutch HF 
Knowledge 
Scale 
Significant improvement in 
intervention scores compared with 
control group 
 
Intervention: median=17(IQR: 13, 
22) 
Control: median=21(IQR: 17, 25) 
 
Estimated means calculated on: 
http://vassarstats.net/median_range.ht
ml 
 
Estimated means: 
Intervention: M=17.25 (SD= 2.6) 
Control: M=21 (SD=2.45) 
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Author 
(country) 
Sample Control 
group 
Intervention  
Group 
Self care measures 
and timeline 
Other 
measures 
Main Self-Care Finding and  
Cohen’s d 
Cohen’s d = 1.53 
(Effect size calculated) 
 
Hoban et al., 
(2013) 
 
(USA) 
80 
randomised 
(51 female 
29 male) 
 
Intervention 
n = 40 (mean 
age = 76.1) 
 
Control n = 
40 (mean age 
= 80.6) 
Usual care 
– nursing 
visits 2/3 
times per 
week. 
Telemonitoring. 
Patients taught how 
to take BP and 
heart rate. Written 
educational booklet 
provided. Patients 
monitor daily or 
more frequently 
when needed. 
22-item SCHFI 
 
Baseline, 1m, 2m, 3m 
MLHF 
 
 
Report significant difference but 
statistics not reported. 
Mussi et al., 
2013 
 
(Brazil) 
200 
randomised 
(74 females 
126 males) 
 
Intervention 
(n = 101 
(mean age 
=62.49) 
 
Control (n = 
99, mean age 
= 63.37)  
Routine 
follow-up. 
Systematic follow-
up by nurses 
specialised in HF 
patient care through 
home visits on the 
10
th
, 30
th
, 60
th
 and 
120
th
 day after 
discharge, 4 HV’s 
and 4 telephone 
calls 
12-item EHFScB scale 
 
Baseline, 1m, 2m, 4m 
Clinical 
congestion score 
 
HF knowledge 
questionnaire 
Significant improvement for both 
groups and at 4m – scores sig. better 
in intervention compared with 
control group: 
 
Intervention: M=22.36 (SD=6.46) 
Control: M=30.91 (SD=7.30) 
 
Cohen’s d – 1.24 
(Effect size calculated) 
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Author 
(country) 
Sample Control 
group 
Intervention  
Group 
Self care measures 
and timeline 
Other 
measures 
Main Self-Care Finding and  
Cohen’s d 
Oliveria et 
al., 2017 
 
Brazil 
44 
randomised 
(30 males, 14 
females) 
 
Intervention 
n = 19 (mean 
age = 60.5)  
 
Control n = 
17 (mean age 
= 60.0) 
Standard 
outpatient 
monitoring 
at HF clinic  
12 telephone calls, 
weekly, then bi 
weekly for the 
following 2 
months. 
Pharmacological 
and non-
pharmacological 
adherence was 
discussed and info 
about the disease 
and self-care were 
provided.  
12-item EHFScB 
 
Baseline, 2m, 4m 
HF knowledge 
questionnaire 
At 4m: sig difference in intervention 
compared to control group 
 
Intervention: M=25.4 (SD=6.6) 
Control: M=29.5 (SD=4.8) 
 
Cohen’s d = 0.71. 
(Effect size calculated) 
 
Rahmani et 
al., 2017 
 
(Iran) 
80 
randomised 
(46 female 
34 male) 
 
Intervention 
n = 40 (mean 
age = 67.5) 
 
Control n = 
40 (mean age 
= 69.47) 
 
Routine 
care 
Continuous care 
model Four phases: 
 
1). Orientation-
understanding of 
the problem, 
motivating and 
discussion of 
follow-up process. 
2). Educational 
content via 
telephone, lectures, 
booklets, training 
package, CD’s. 
3). Follow up via 
telephone every 
22-item SCHFI 
 
Baseline, 1m, 3m. 
None At 3m: Sig. improvement in scores 
for intervention group but not control 
group. 
 
Maintenance: Scores sig. better in 
intervention group compared with 
control group: 
 
Intervention: M=49.86 (SD= 12.58) 
Control: M=23.39 (SD=10.83) 
 
Cohen’s d=2.26 
(Effect size calculated) 
 
Management: Scores sig. better in 
intervention group than control 
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Author 
(country) 
Sample Control 
group 
Intervention  
Group 
Self care measures 
and timeline 
Other 
measures 
Main Self-Care Finding and  
Cohen’s d 
week for three 
months. 
4). Evaluation 
phase – month after 
intervention. 
group: 
 
Intervention: M=55.38(SD=15.06) 
Control: M=34.50(SD= 10.24) 
 
Cohen’s d =1.65 
(Effect size calculated) 
 
Confidence: Scores sig. better in 
intervention group compared with 
control group: 
 
Intervention: M=45.82 (SD=16.27) 
Control: M=29.51 (SD=21.98) 
 
Cohen’s d=0.8 
(Effect size calculated) 
Sezgin et al., 
2017 
 
(Turkey) 
90 
randomised 
(21 females, 
69 males) 
 
Intervention  
n = 42 (mean 
age = 60.75) 
 
Control n = 
44 (mean age 
= 65.86) 
Standard 
care 
Educational 
booklet, daily 
follow-up chart to 
record weight, 
edema status, BP, 
pulse, medication. 
Magnet-held set 
provided to record 
factors/situations 
that may require 
visit to 
clinic/emergency 
22-item SCHFI 
 
 
Baseline, 3m, 6m  
LVDS 
 
Rehospitalisatio
n 
 
At 6m, sig difference in scores 
between intervention group 
compared with control group: 
 
Maintenance: Intervention: M=71.54 
(SD= 19.50) 
Control: M=40.21(SD=14.43) 
 
Cohen’s d=1.8 
(Effect size calculated) 
 
Management: Intervention: 
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Author 
(country) 
Sample Control 
group 
Intervention  
Group 
Self care measures 
and timeline 
Other 
measures 
Main Self-Care Finding and  
Cohen’s d 
 room. Phone calls 
every 2 weeks for 6 
months.  
M=63.33(SD= 21.37) 
Control M=29.00(SD= 17.98) 
 
Cohen’s d = 1.74 
(Effect size calculated) 
 
Confidence: 
Intervention: M=69.68(SD=22.54) 
Control: M= 42.99(SD=16.90) 
 
Cohen’s d=1.35 
(Effect size calculated) 
 
Shively et 
al., 2013 
 
(USA) 
84 
randomised 
(1 female 
83 males) 
 
Intervention 
n = 43 (mean 
age = 63.4) 
 
Control n = 
41 (mean age 
= 68.9) 
Routine 
medical 
care 
Tailored 
programme of 
individualised self-
selected goals and 
moving the patient 
to a higher level of 
activation. Health 
behaviour goals 
determined, 
progress towards 
goals was 
reinforced. Self-
management tool 
kit provided. 
15-item SCHFI 
 
 
Baseline, 3m, 6m 
PAM 
 
MOS 
 
Specific 
Adherence Scale  
 
Hospitalisations  
 
Emergency 
department 
visits. 
No significant group by time 
interactions for self-care 
maintenance, management or 
confidence scales and no significant 
interaction effects for group by PAM 
level by time interaction for SCHFI 
scales. 
(Statistics not reported) 
Souza et al., 
2014 
252 
randomised 
Standard 
treatment 
4 home visits and 4 
telephone calls. 
12-item EHFScB scale 
 
HF knowledge 
questionnaire  
Sig. better scores in Intervention than 
Control group at 6m:  
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Author 
(country) 
Sample Control 
group 
Intervention  
Group 
Self care measures 
and timeline 
Other 
measures 
Main Self-Care Finding and  
Cohen’s d 
 
(Brazil) 
(94 females 
158 males) 
 
Intervention 
n = 123 
(mean age = 
62) 
 
Control n = 
129 (mean 
age = 63) 
approach Knowledge of 
disease, self-care 
behaviour 
adherence, weight 
control, hydro-
saline restriction, 
physical and annual 
vaccination was the 
focus of HV’s and 
telephone contact.  
Baseline, 1m, 2m, 4m, 
6m.  
 
 
 
 
 
Intervention: M=22.7(SD=7.0) 
Control: M=30.2(SD=7.0) 
 
Cohen’s d = 1.07 
(Effect size calculated) 
 
Yu et al., 
2015 
 
(China) 
178 
randomised 
(87 females 
91 males) 
 
Intervention 
group n = 90 
(mean age = 
78.6) 
 
Control 
group n = 88 
(mean age = 
78.7) 
 
Standard 
care 
Pre-discharge 
visits, home visits, 
intensive telephone 
follow-up and 
telephone access to 
cardiac nurse. 
Educational and 
supportive 
interventions. 
Telephone call 
every 2 weeks for 3 
months then every 
2 months for 6 
months. 
18-item SCHFI 
 
Baseline, 6 weeks, 3m, 
9m. 
Dutch HF 
knowledge scale 
 
MLHFQ 
 
EQ-5D 
At 9m: 
Maintenance: Scores better in 
intervention than Control: 
 
Intervention: M=53(SD=21.1) 
Control: M=40.1(SD=20.5) 
Cohen’s d = 0.62 
(Effect size calculated) 
 
Management: Scores better in 
intervention than control: 
 
Intervention: M=80.0(SD=14.1) 
control: M=74.0(SD=16.6) 
 
Cohen’s d = 0.39 
(Effect size calculated) 
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Author 
(country) 
Sample Control 
group 
Intervention  
Group 
Self care measures 
and timeline 
Other 
measures 
Main Self-Care Finding and  
Cohen’s d 
Confidence: Scores better in 
intervention than control: 
 
Intervention: M=38.6(SD=20.6) 
Control: M=25.5(SD=15.1) 
 
Cohen’s d = 0.73 
(Effect size calculated) 
 
NB: Self Care outcome measure terms: European Heart Failure Self-Care Behaviour Scale (EHFScB scale) and Self-Care Heart Failure Index (SCHFI). 
Other outcome measure terms: Geriatric Depression Scale (GDS), EuroQol-5Dimensions (EQ-5D), Health Related Quality of Life (HRQoL), Heart Failure 
Knowledge Test (HFKT), Kansas City Cardiomyopathy Questionnaire (KCCQ), Left Ventricular Dysfunction Scale (LVDS), Left Ventricle Ejection Fraction 
measure (LVEF), Medical Outcomes Study (MOS), Minnesota Living with Heart Failure Questionnaire (MLHFQ), Patient Activation Measure (PAM), Short 
Form Health Survey 12 (SF-12), Swedish version of Health Survey (SF-36), Heart Failure Somatic Perception Scale (HFSPS). 
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Characteristics of interventions 
All interventions were nurse-led and could be categorised as one of two broad forms. 
The first type of intervention involved education and skills building, with the aim of 
improving participants’ HF knowledge, improving their ability to monitor their 
symptoms, for example, heart rate, blood pressure, weight, and finally, improving 
their self-care behaviours, such as adherence to medication, weight and dietary 
control, fluid control and levels of exercise. The method of delivery varied between 
studies. Three studies (Boyne et al., 2014; Hagglund et al., 2015; Hoban et al., 2013) 
delivered the educational content via a telemonitoring device, which was installed into 
the participant’s home. The device included stored information about HF, treatment 
advice, medication dosage, and guidance to monitor symptoms. Participants could use 
the device to record and evaluate their own perceived health and to report any 
symptoms that they were concerned about. This was monitored by nursing staff, and 
was followed up by telephone contact. Five of the studies involved delivering the 
educational content and skills building via a combination of home visits (HV) and 
telephone calls (Clark et al., 2015; Mussi et al., 2013; Rahmani et al., 2017; Souza et 
al., 2014; Yu et al., 2015). Two of the studies (Sezgin et al., 2017; Oliveria et al., 
2017) delivered the educational content via outpatient appointments. Finally, one 
study (Dracup et al., 2014) included two intervention groups, as well as the control 
group. The aim of this study was to investigate the impact of two different intensity 
levels of HF education and self-care enhancement. 
The second type of intervention involved a tailored intervention approach, which 
focused on increasing motivation and activation levels. One intervention was based on 
Activation theory (Shively et al., 2013) and aimed to increase participants’ activation 
levels by determining self-selected goals and increasing levels of activation over a 
six-month period. Creber et al’s, (2016) study involved a Motivational Interviewing 
tailored intervention. Participants identified specific client-centred goals related to HF 
self-care and establishing a client-directed plan, setting smaller daily goals in the 
context of aiming to achieve the overall self-defined goal. Participants were supported 
by nursing staff to achieve their HF self-care goals.  
As mentioned, the delivery and follow-up of educational content and monitoring of 
participants was either via a telemonitoring device, attendance at outpatient 
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appointments, HV’s, telephone contact, or a combination of all of these methods. The 
number of outpatient appointments, HV’s and telephone calls varied between studies. 
It was difficult to determine the number of contacts within studies. Of the studies 
which reported the number of contacts, the range was between 2-12 HV’s and 4-19 
telephone calls. Some studies identified that the number of contacts depended on level 
of need of the participants, those who required more support received more contact 
from nurses. This undoubtedly impacts the standardisation of the intervention.  
All studies had one control group, which was described as treatment as usual (TAU) 
or routine care. It was difficult to determine the length of the interventions, however, 
the overall range of data collection was between three and 24 months, with an average 
of three time points for data collection (range 2 – 5). Four studies collected data up to 
three months (Creber et al., 2016; Hagglund et al., 2015; Hoban et al., 2013; Rahmani 
et al., 2017), two studies collected data up to four months (Mussi et al., 2013; Oliveria 
et al., 2017), three studies collected data up to six months (Sezgin et al., 2017; Shively 
et al., 2013; Souza et al., 2014), two studies collected data up to nine months (Clark et 
al., 2015; Yu et al., 2015), one study collected data for 12 months (Boyne et al., 2014) 
and one study collected data for 24 months (Dracup et al., 2014). 
Self-care outcome measures 
All thirteen studies administered one of two valid and reliable self-care outcome 
measures: the Self-Care Heart Failure Index (SCHFI, v4 and v6.2) (Riegel, Carlson, 
Moser, Sebern et al., 2014) or the European Heart Failure Self-Care Behaviour Scale 
(EHFScB scale) (Jaarsma, Stromberg, Martensson, & Dracup, 2003). There were 
three versions of the SCHFI administered (15-, 18-, or 22-items). It is a self-report 
scale with items rated on a four-point scale and divided into three subscales measuring 
self-care maintenance, self-care management and self-care confidence (Vellone, 
Riegel, Cocchieri, Barbaranelli et al., 2013). The EHFScB scale is either a 9- or 12-
item scale, items rated on a five-point scale, which measures changes in behaviours 
over time. The scale is available in over 14 languages (Jaarsma et al., 2003).  
Self-care outcome results 
The majority of the results reported are based on differences in scores between the 
intervention group and control group at final data collection point. For two studies 
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(Clark et al., 2015; Shively et al., 2013) the results are based on improvements over 
time. Results are reported according to intervention type and outcome measure used to 
measure self-care. Five studies, which provided an education, skills building and 
nursing follow-up intervention, measured self-care outcomes using the SCHFI (Clark 
et al., 2015; Hoban et al., 2013; Rahmani et al., 2017; Sezgin et al., 2017; Yu et al., 
2015). Three of these studies (Rahmani et al., 2017; Sezgin et al., 2017; Yu et al., 
2015) reported significantly better self-care outcome scores in the intervention group 
compared with the control group by end of follow-up. This result was found in all 
three domains of the SCHFI: self-care maintenance (d=2.26; d=1.80; d=0.62), self-
care management (d=1.65; d=1.74; d=0.39) and self-care confidence (d=0.8; d=1.35; 
d=0.73). Clark et al. (2015) reported significantly improved scores over time for the 
intervention group compared with control group for self-care maintenance (d=0.40) 
and self-care confidence scores (d=0.68). In terms of self-care management scores, 
they reported an improvement over time in self-care outcome scores in intervention 
group but not control group (U=16.00, df=1, p=0.03). Effect sizes could not be 
calculated for this result. Hoban et al. (2013) reported that patients in the intervention 
group showed higher scores in questions related to physical activity and weighing 
themselves more frequently, compared with control group, but no statistics or data 
were available to support this finding. 
Six studies (Boyne et al., 2014; Dracup et al., 2014; Hagglund et al., 2015; Mussi et 
al., 2013; Souza et al., 2014; Oliveria et al., 2017) also involved educating 
participant’s on HF knowledge, symptoms and behaviours, however, they measured 
changes in self-care behaviours using the EHFScB Scale. By end of follow-up, five 
studies reported significant differences in self-care scores in the intervention group 
compared with the control group (see Table 1 for respective effect sizes). However, 
Dracup et al. (2014) found no significant differences between the intervention and 
control group by 24 months. 
In relation to applying a motivational interviewing approach and developing client-
centred goals, Creber et al. (2016) found that after three months, scores in self-care 
maintenance were significantly better in the intervention group compared with control 
group (d=0.44). There was a difference in self-care confidence scores but the effect 
was non-significant (d=0.26). They did not report differences in self-care 
management. The authors explained that patients reported being asymptomatic 
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therefore self-care management scores could not be calculated. Finally, in relation to 
aiming to improve self-care behaviours by increasing activation levels, Shively et al. 
(2013) reported no improvements in self-care maintenance, confidence or 
management between their intervention and control groups. Effect sizes could not be 
calculated for each self-care domain of the SCHFI.  
Other outcomes of interest 
In addition to self-care, studies were interested in the impact of the interventions on 
other outcomes, such as, number of hospitalisations (Dracup et al., 2014; Hoban et al., 
2013; Sezgin et al., 2017; Shively et al., 2013; Souza et al., 2014), adherence (Boyne 
et al., 2014; Hagglund et al., 2015; Mussi et al., 2013) HF knowledge (Boyne et al., 
2014; Clark et al., 2015; Hagglund et al., 2015; Mussi et al., 2013; Oliveria et al., 
2017; Yu et al., 2015) QoL (Clark et al., 2015; Hoban et al., 2013; Sezgin et al., 2017) 
and cardiac death (Dracup et al., 2014; Souza et al., 2014; Yu et al., 2015).  
In relation to number of hospitalisations, four studies (Dracup et al., 2014; Hoban et 
al., 2013; Sezgin et al., 2017; Yu et al., 2015) found no differences between offering 
education and skills building, compared with TAU. Improving activation levels was 
reported to have lowered number of hospitalisations in intervention group compared 
with control group, by end of follow-up (Shively et al., 2013). Education on HF 
knowledge was found to improve participant’s knowledge compared with TAU group 
for four studies (Clark et al., 2015; Mussi et al., 2013; Oliveria et al., 2017; Souza et 
al., 2014). However Boyne et al. (2014) did not find this at 12-month follow-up. In 
terms of adherence to treatment plan, education intervention studies found that by end 
of follow-up, there was a significant improvement in adherence scores for 
intervention group but not control group (Boyne et al., 2014); Mussi et al., 2013). 
Two studies found that education and skills building improved QoL, compared with 
TAU (Clark et al., 2015; Hoban et al., 2013). However, Sezgin et al. (2017) did not 
find this to be the case. Finally, in relation to cardiac death, two studies, which 
provided education and nursing follow-up, did not find any differences in number of 
cardiac deaths, compared with control group (Dracup et al., 2014; Sezgin et al., 2017). 
Risk of Bias 
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As mentioned, two assessors evaluated each article, assigning ‘low’, ‘high’ or 
‘unclear’ risk of bias across all seven domains. Inter-rater agreement was high for all 
papers (89%) and any disagreements were resolved by discussion. Based on Higgins 
et al. (2011), an overall risk of bias was determined for each study (see Figure 2). All 
but three studies (Boyne et al., 2014; Dracup et al., 2014; Mussi et al., 2013) were 
rated as overall ‘high’ risk of bias. Only one study Dracup et al. (2014) was rated as 
having an overall ‘low’ risk of bias. It is important that these are taken into account 
when considering the results of the studies and as such, findings must be interpreted 
with caution. A detailed breakdown of the risk of bias ratings can be found in 
Appendix 3.  
The areas of the lowest bias across all studies was in the domain of randomisation 
(69.2%). Method of randomisation was reported in all but four studies (Clark et al., 
2015; Creber et al., 2016; Hagglund et al; 2015; Rahmani et al., 2017). Three areas 
were difficult to assess, mostly because studies failed to provide details. These were in 
relation to allocation concealment, and details about blinding of participants, 
personnel and outcome assessment. This information was rarely reported, 64.1% of 
the data was assessed as ‘unclear’ risk of bias.  
‘High’ risk of bias was reported in four domains. In relation to blinding of outcome 
assessment, two studies (Clark et al., 2015 and Sezgin et al., 2017) highlighted that 
nurses involved in interventions also collected outcome measure data from 
participants. Three studies were assessed as ‘high’ risk of bias in the incomplete 
outcome data domain (Creber et al., 2016; Hagglund et al., 2015; Shively et al., 
2013). These were related to high dropout, participant numbers not balanced across 
groups and missing data. In relation to selective reporting, five studies (Clark et al., 
2015; Creber et al., 2016; Hoban et al., 2013; Rahmani et al., 2017; Shively et al., 
2013) were assessed as being ‘high’ risk of bias in this domain, related to outcome 
data not being reported as expected, or missing data. Finally, for the ‘Other’ domain, 
seven studies were assessed as ‘high’ risk of bias, due to small sample sizes, no power 
calculation, equipment malfunctions, and method of selection (Clark et al., 2015; 
Hoban et al., 2013; Oliveria et al., 2017; Rahmani et al., 2017; Shively et al., 2014; 
Souza et al., 2014; Yu et al., 2015).  
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Figure 2. Risk of Bias Assessment 
 
S
E
L
E
C
T
IO
N
 B
IA
S
 
P
E
R
F
O
R
M
A
N
C
E
 B
IA
S
 
 D
E
T
E
C
T
IO
N
 B
IA
S
 
 A
T
T
R
IT
IO
N
 B
IA
S
 
 R
E
P
O
R
T
IN
G
 B
IA
S
 
O
T
H
E
R
 B
IA
S
 
 
Low Risk  
Unclear Risk  
High Risk  
R
a
n
d
o
m
 s
e
q
u
e
n
c
e
 g
e
n
e
ra
ti
o
n
 
A
ll
o
c
a
ti
o
n
 c
o
n
c
e
a
lm
e
n
t 
B
li
n
d
in
g
 o
f 
p
a
rt
ic
ip
a
n
ts
 a
n
d
 
p
e
rs
o
n
n
e
l 
B
li
n
d
in
g
 o
f 
o
u
tc
o
m
e
 a
s
s
e
s
s
m
e
n
t 
In
c
o
m
p
le
te
 o
u
tc
o
m
e
 d
a
ta
 
S
e
le
c
ti
v
e
 r
e
p
o
rt
in
g
 
O
th
e
r 
 
O
v
e
ra
ll
 R
is
k
 o
f 
b
ia
s
 
Boyne et al. (2014) 
               
Clark et al. (2015) 
                
Creber et al. (2016) 
                
                          Dracup et al. (2014) 
               
Hagglund et al. (2015)                 
                                  Hoban et al. (2013)                 
Mussi et al. (2013) 
                
Oliveria et al. (2017) 
                
Rahmani et al. (2017) 
                
Sezgin et al. (2017) 
                
Shively et al. (2013) 
                
Souza et al. (2014) 
                
Yu et al (2015) 
                
  29 
Discussion 
Self-care has been shown to be an important component in successful HF 
management (Harkness et al., 2015). This review attempted to identify and review 
RCTs that aimed to improve self-care behaviours in people with HF. Thirteen studies 
were identified that assessed self-care behaviours using either one of two measures: 
the SCHFI and the EHFScB scale.  
Despite a review by Boyde, Turner, Thompson and Stewart, (2011) which found 
variable results associated with providing education interventions and HF-related 
outcomes, 11 of the 13 studies reviewed involved providing an intensive education 
and skills-building package. Of these 11 studies, 10 reported significant 
improvements in scores related to self-care that lasted until the end of the follow-up 
period. Only one study (Dracup et al., 2014) reported no differences in self-care 
scores by end of follow-up. Interestingly, this study had the lengthiest follow-up 
period, 24 months. By 24 months, there were no differences in scores related to self-
care. 
Two studies attempted to improve motivation and activation levels of patients by 
focusing on goal-directed outcomes. Shively et al. (2013) found no improvements in 
the groups, and Creber et al. (2016) only found scores in the self-care maintenance 
domain to be significantly better in the intervention group compared with the control 
group. 
Interestingly, the three studies which introduced a telemonitoring device into patients’ 
homes to support them to monitor their own symptoms, reported significantly better 
self-care scores for patients who had the telemonitor device, compared with patients 
in the ‘treatment as usual’ groups (Boyne el al., 2014; Hagglund et al., 2015; Hoban et 
al., 2013). This supports a review of telemonitor support for patients with HF (Clark, 
Inglis, McAlister, Cleland, Stewart, 2007). 
Risk of bias were identified in all but one study (Dracup et al., 2014). This was mostly 
due to lack of reporting information regarding blinding and information on reporting 
outcome data, which, as a result, required risk of bias to be assessed as ‘unclear’. Ten 
studies received at least one score of ‘high’ risk of bias. This was due to reporting of 
outcomes, missing data, small sample sizes, biases between the groups and not 
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conducting power calculations. Overall, 10 out of the 13 studies received an overall 
‘high’ risk of bias score, and these limitations need to be taken into consideration 
when interpreting and generalizing these RCT results. It is important to note that 
every study which reported ‘large’ effect sizes were also rated to be overall ‘High’ 
risk of bias. A review by Wykes, Steel, Everitt and Warrier (2008) highlights that 
methodological attributes, such as masking participants to groups, may impact and 
inflate the treatment effects. As such, the results from these studies should be 
interpreted with caution.  
Limitations of current review 
Several limitations of this review should be considered when interpreting its findings. 
Despite that every attempt was made to produce an exhaustive account of all of the 
relevant research on the topic, there is a possibility that some studies may have been 
missed. Added to this, there was no measure of inter-rater reliability at the abstract 
screening stage. While beyond the scope of this project, normal practice would be that 
more than one person would review all of the titles and abstracts of search results. 
This improves reliability but also reduces the chance for human errors. Unpublished 
studies were excluded from the review and it is important to consider that this which 
will have introduced publication bias. The decision to limit search criteria solely to 
include RCT designed studies provided a focused assessment and enabled risk of bias 
evaluation; however, the breadth of developing evidence aimed at improving self-care 
behaviours is unlikely to be fully represented. Other limitations of this review are 
related to the features of the individual studies. Even though every study highlighted 
the time points for collecting outcome measures, it was difficult to determine the 
difference between intervention length and follow-up period. Also, some studies were 
clear about the number of HVs and telephone calls that were made to participants, but 
some studies didn’t specify the number of HVs and telephone calls. There was also 
variation within studies in relation to the number of HV’s and telephone calls that 
participants received. This makes it difficult to draw firm comparisons and 
conclusions about what is an effective timescale to offer HVs and telephone calls in 
order to try to improve self-care behaviours. 
Clinical implications and future research 
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Generally the results suggest that patients show better outcomes when they are given 
extra support in addition to standard outpatient appointments. Research suggests that 
patients tend to avoid seeking medical care when symptoms begin to escalate (Moser, 
Dickson, Jaarsma, Lee, Stromberg et al., 2012). Therefore, added support and input 
from nursing staff can monitor patients and encourage them to manage their 
symptoms better. A review by McAlister, Stewart, Ferrura and McMurry (2004), 
concluded that follow-up input from the multi-disciplinary team reduced mortality 
and all-cause hospitalisations.  It would be interesting to attempt to quantify the 
optimum length of input that patients should receive following diagnosis of HF and 
discharge from hospital. Also, to determine the optimum number of HVs or telephone 
visits that patients should receive. These aspects were difficult to determine from 
review of included studies.  
Conclusions 
This was the first review to synthesize RCTs examining the impact of interventions 
on improving self-care behaviours, using reliable and valid outcome measures to 
assess self-care behaviours. The findings suggest that patients may be more likely to 
engage in self-care behaviours when they get extra support and education from 
nursing staff than when they simply attend routine outpatient appointments. It is 
important to note that risk of bias was identified in all but one study. As a result, it is 
not possible to determine the effectiveness of self-care interventions without 
methodologically robust research.  
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Plain English Summary 
 
Background: People who have a severe mental illness (SMI) are two to 
three times more likely to develop a heart problem, such as heart failure 
(HF). At present there is no qualitative research investigating peoples’ 
experiences of living with a SMI and HF. 
Aims: This study aimed to explore peoples’ experience of living with 
both a SMI and HF. It aimed to understand individuals’ understanding of 
their illnesses and the factors influencing how they manage the demands 
of these illnesses. 
Methods: Three people with a diagnosis of an SMI and HF were 
interviewed. Semi-structured interviews were used, enabling the 
researcher to explore their experiences in greater depth. The interviews 
were recorded, transcribed and analysed using Interpretative 
Phenomenological Analysis, which emphasises the importance of 
individuals’ experiences and how they makes sense of these experiences.  
Results: Three main themes were identified from the participants’ 
accounts. These themes were focused on the experience of being ill, 
changes and adjustments that were made as a result of being ill, and the 
role of others in helping to manage their illnesses.  
Applications: Participants described a range of experiences and it is 
hoped that these findings can inform developments in relation to the care 
that individuals receive from healthcare professionals working in both 
mental and physical healthcare settings. This study has highlighted a need 
for greater integration between mental and physical health. 
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Abstract 
Background: People living with a severe mental illness (SMI) are at greater risk of 
developing heart failure (HF) than the general population. Reasons for this are 
complex however antipsychotic medication, poor diet, sedentary behaviour, smoking, 
use of alcohol contribute to increased risk. At present little is known about the 
experience of people living with both of these illnesses.  
Aims: The aim of this study is to describe the experience of people with a SMI and 
HF. Specifically, to determine individuals’ understanding of their illnesses and the 
factors influencing their ability to manage their illnesses.  
Methods: The study was designed following the principles of Interpretative 
Phenomenological Analysis (IPA). Three participants provided their informed consent 
to participate in semi-structured interviews exploring their experiences of living with 
a SMI and HF. Interviews were transcribed and analysed in line with IPA 
methodology. 
Results: Three main themes were identified from the participants’ accounts. The first 
theme was focused on the experiences of becoming ill, trying to make sense of and 
coming to terms with their illnesses. The second theme was related to the changes and 
adjustments that were made as a result of being ill, such as lifestyle changes. The third 
theme identified the importance of others in supporting participants to manage their 
illnesses. The themes were inter-related by the emotions experienced by participants 
across all three themes. 
Applications:  articipants’ accounts provided valuable insights into the complex 
nature of comorbidity, and highlighted implications for clinical practice, service 
provision and future research. 
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Introduction 
There is longstanding evidence to suggest that people living with a severe mental 
illness (SMI), such as schizophrenia or bipolar disorder, are less likely to have their 
physical health needs identified, or to receive appropriate treatment for these (The 
King’s Fund; Mitchell & Lord, 2010; Smith, Langan, McLean,  uthrie & Mercer, 
2013). Heart Failure (HF) is a cardiac condition that occurs when the heart fails to 
pump blood around the body as effectively as it used to (The British Heart 
Foundation; BHF). HF is one of the predominant causes of the 10- to 20- year 
reduction in life expectancy for people with a SMI (Crump, Winkleby, Sundquist & 
Sundquist et al., 2013; Laursen, 2011; Lawrence, Hancock & Kisely, 2013). Risk 
factors associated with prescribed antipsychotic medication and also behavioural 
health risks such as poor dietary habits, smoking, use of alcohol, obesity, living a 
sedentary lifestyle increase the likelihood of developing HF (Meyer, 2001; Ringen, 
Engh, Birkenaes, Dieset et al., 2014; Shulman, Miller, Misher & Tentler, 2014). In 
addition, research has also shown that the risk of developing HF is under-recognised 
and under-recorded in people with a SMI (McLean, Langan, Martin, Guthrie et al., 
2014; Smith et al., 2013) and that even when physical health problems are identified, 
people living with a SMI have a lower chance of receiving the appropriate care for HF 
(Jorgensen, Mainz, Egstrup & Johnsen 2017; Mitchell, Lord & Malone, 2012).  
People living with a SMI and HF are likely to be required to commit to a complex 
treatment plan and strict self-care maintenance behaviours (Brannstrom, Ekman, 
Norberg, Bowan et al., 2006; Levensky, O’Donohue & William, 2006). They are 
likely to have been prescribed a range of medications for their illnesses requiring 
adherence on a daily basis. In addition, they may be required to attend regular clinic 
appointments, and they may have been advised to engage in some form of exercise, 
stop smoking and change their dietary habits. Making these changes is likely to 
require significant lifestyle changes, to acquire good self-care habits and to implement 
multiple adaptive and coping behaviours (Gallacher, May, Montori & Mair, 2011; 
Riegel, Lee & Dickson, 2011; Roe, Yanos & Lysaker, 2006) and individuals may 
struggle to maintain their treatment regimen. Therefore non-adherence is an important 
concern (Ho, Bryson & Rumsfeld, 2009) as this compromises the effectiveness of the 
available treatment, increases risk of relapse, interferes with recovery, can lead to 
hospitalisation and in many cases can lead to death (De las Cuevas, Penate & Cabrera, 
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2016; Levensky & O’Donohue, 2006; Owen-Smith, Stewart, Green, Ahmedani et al., 
2016).  Research has shown that factors such as patients’ attitudes and beliefs about 
their illness, levels of depression and anxiety, symptom severity, access to appropriate 
support from family and the healthcare system, and socioeconomic deprivation impact 
on adherence (Graven & Grant, 2013; Riegel, Moser, Anker, Appel et al., 2009; Roe 
et al., 2006; Velligan, Weiden, Sajatovic, Scott et al., 2009). 
People with a SMI have been found to struggle to cope with their illness, and to 
adhere to their treatment regimen (Gilmer, Dolder, Lacro, Folsom et al., 2004; 
Haddad, Brain & Scott, 2014; Nelson, Graham, Lindsey & Rasu, 2011; Owen-Smith 
et al., 2016; Roe et al., 2006). People with HF have also been found to struggle (Chin 
& Goldman, 1997; Cole, Norman, Weatherby et al., 2006). It is likely, then, that those 
with both a SMI and HF may be likely to struggle with a more complex and 
demanding treatment plan. However, little is known about the experiences of people 
living with a SMI and HF. It may be that some of the factors highlighted above 
impact someone living with a SMI and HF. It may be that there are factors that are 
important for this population that have not yet been highlighted. It is important to 
identify and understand these factors, so that supports and treatments can be put in 
place to improve the quality of care and the quality of life for these patients.  
Qualitative research, in particular, Interpretative Phenomenological Analysis (IPA), is 
particularly appropriate to explore the experiences of patients with SMI and HF, as it 
explores the idiographic subjective experiences of individuals, how they ascribe 
meaning to their experiences and how they make sense of their world (Biggerstaff & 
Thompson, 2008; Holland, Thomson & Henderson, 2006).  
Aim 
The aim of this study is to describe the experience of people with a SMI and HF. 
Specifically, to explore participants’ understanding of their illnesses and the factors 
influencing how they manage their illnesses.  
Method 
Design 
The present study adopted a qualitative design to enable the exploration of the 
experience of living with SMI and HF. IPA focuses on meaning-making and is 
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concerned with the detailed examination of personal experiences, perceptions, and 
views of the participants (Smith, Flowers & Larkin, 2009). With its theoretical 
foundations in phenomenology, hermeneutics and idiography, IPA focuses on the 
world as it is being experienced by the individual. IPA attempts to analyse, interpret 
and then present an account of the ways in which people experience specific and 
important events in their lives (Kaselionyte & Gumley, 2017; Smith et al., 2009).  
Interviews 
The aim of the interview was for the interaction to be defined more by the person 
rather than researcher-led assumptions or questions, in order to implement I A’s 
inductive epistemology (Smith et al., 2009). Semi-structured interviews (Appendix 5) 
were chosen for their tendency to produce rich data. They provide the participants the 
opportunity to freely tell their stories, reflect on their experiences, and introduce novel 
issues (Kaselionyte & Gumley, 2018; Smith et al., 2009). The content of the semi-
structured interview was developed in collaboration with the researcher’s field 
supervisor, a clinical psychologist, working with patients who have heart problems 
and significant mental health difficulties. The duration of interviews ranged from 45-
65 minutes (average 60 minutes). All interviews were recorded before being 
transcribed verbatim and anonymised by the researcher, with identifying information 
removed. 
Procedure 
Prior to commencing recruitment, ethical approval was obtained from the East of 
Scotland Research Ethics Committee (Appendix 6-17/ES/0125) Research and 
Development Management Approval was obtained for NHS GGC (Appendix 7-
GN17MH446), and Caldicott guardian approval from NHS GGC was obtained 
(Appendix 8). Recruitment took place between October 2017 and March 2018. There 
were two methods of recruitment. The first method was via consultation with staff 
from the Cardiology teams throughout NHSGGC. HF nurses, pharmacists and 
cardiologists were provided with standard information leaflets (Appendix 9) and were 
asked to consider, in collaboration with researcher, patients on their caseload who 
may be eligible for inclusion in the study. The second method involved data linkage 
between two independent datasets maintained by Cardiology services and mental 
health services in NHSGGC. Individual patient CHI numbers provided by the HF 
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team were cross-matched with the Psychosis Clinical Information System (PysCIS 
database, NHS GGC). Overlapping CHI numbers were given to researcher, who then 
contacted the clinical team to discuss eligibility.  
 
If a potential participant met the eligibility criteria and was judged by the clinical 
team as stable, the potential participant’s next appointment date was discussed and it 
was agreed that the clinician would provide the participant the Participant Information 
Sheet (PIS) (Appendix 10) and ask the potential participant if they agreed to the 
researcher contacting them. When feasible, the researcher was available during clinics 
to offer potential participants the opportunity to discuss or ask questions about the 
study. Potential participants who agreed were contacted via telephone at least 24 
hours following their appointment. Further information was provided about the study 
and a pre-screen was conducted to determine current mental state and overall 
wellbeing, to determine if the person was still eligible to go ahead with the study. 
They were asked to report on their mental health diagnosis (as was not clear in 
medical notes). They were informed that a letter would be sent to their GP and 
nurse/cardiologist (Appendix 11) to make them aware that their patient was 
participating in the study. Following this, and if judged by researcher to be physically 
and mentally well, an interview was arranged. All interviews took place at the 
potential participant’s    surgery. Written informed consent was obtained prior to 
commencing the interviews (Appendix 12). 
Participants 
Participants were English speaking, over the age of 18, who were diagnosed and 
receiving treatment for HF and had a diagnosis of schizophrenia, psychosis or bipolar 
disorder. They were prescribed either a mood stabiliser (lithium) and/or an anti-
psychotic (e.g. clozapine, olanzapine, risperidone, quetiapine). They were judged to 
be physically and mentally well enough to participate (based on clinical judgement of 
the clinical team in the first instance, and then by researcher’s clinical judgement at 
initial telephone contact, and on day of interview) with no other medical comorbidity. 
Potential participants were excluded if they had a diagnosed learning disability, were 
judged to lack capacity, or were currently unwell (e.g. psychiatric hospitalisation 
within the last 6 months). Those who were not competent in understanding questions 
in English were also excluded.  
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A total of 11 potential participants were identified using the recruitment methods. 
Four were judged by the clinical team to be too unwell (one receiving palliative care, 
two had recent hospitalisations, one judged to be too anxious) to participate. Two 
people did not attend appointments. Finally, two people were judged to lack capacity 
and could not give informed consent. Three individuals gave informed and written 
consent to participate in the current study. A summary of participant characteristics is 
shown in Table 1 below. Pseudonyms were assigned to maintain anonymity.  
According to Pietkiewicz and Smith (2014), there is no rule regarding how many 
participants should be included in an IPA study. They highlighted that the number 
should depend on: the depth of analysis of a single case study; the richness of the 
individual cases; how the researcher wants to compare or contrast single cases; and 
the pragmatic restrictions (such as time constraints or access to participants) one is 
working under. Braun and Clarke (2013) have suggested that sample sizes should be 
adequate to ensure there are enough data to develop a rich story yet not too much that 
time and resources limit a deeper analysis of the data. Similarly, Smith et al., (2009) 
highlight that sample size is contextual in IPA and must be considered on a study-by-
study basis. Hefferon and Gil-Rodriguez (2011) have said that given the idiographic 
focus in I A, “less is more” in terms of sample size and that fewer participants 
examined at a greater depth is always preferable to a broader, shallow and simply 
descriptive analysis of many individuals. 
Table 1:  articipants’ Demographic Information 
Participant  Jack Mary Jane 
Age (years) 48 56 51 
Gender Male Female Female 
Ethnicity White Scottish White Scottish White Scottish 
SMI diagnosis 
(medication) 
Schizophrenia 
(clozapine) 
Psychosis 
(clozapine) 
Bipolar disorder 
(lithium) 
Years since HF 
diagnosis 
1yr 2 months 2 years 10 years 
Employment status Unemployed Unemployed Unemployed 
Marital status Single Single Single 
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Data analysis  
IPA was used to analyse the transcripts, following a number of recognised stages 
(Smith et al., 2009). Firstly, each transcript was read repeatedly, allowing the 
researcher to immerse herself and become familiar with the account. A case study for 
each transcript was written, with the intent of trying to understand and to tell the 
participant’s story, staying as close to the participant’s language as possible. Next, 
exploratory descriptive, linguistic and conceptual codes were made on the right hand 
margin of the transcript. Following this, emergent themes were then developed on the 
left hand side of the transcript by identifying patterns between these exploratory codes 
(Appendix 13). Connections and patterns across the emergent themes were then 
identified within the transcript (Idiography). The researcher actively sought to explore 
aspects of the transcript that had not been included in preliminary thematic codes. In 
reviewing these ‘unused’ data existing themes were elaborated and new themes 
constructed ensuring full saturation of the available data within each transcript. This 
process was repeated for each individual case to ensure a thorough analysis of the 
data. Individualised themes were compared to the original case studies (see Appendix 
14 for example of case study) to ensure commitment to idiographic analysis. The 
researcher asked themselves to what extent would participants agree that these case 
summaries and themes were accurate to their experiences and language. Once themes 
had been identified in individual transcripts, overarching superordinate and 
subordinate themes were identified across all transcripts by considering patterns, 
similarities and differences between accounts (Appendix 15). All themes were 
labelled using participants own words to ensure analysis stayed close to participants 
language. A secondary rater (research supervisor) independently rated a sample of the 
transcripts, and discussions of emergent themes identified a good level of 
concordance.  
Researcher reflexivity 
The researcher has a central role in the process of IPA. In particular, it is important to 
consider how the researcher’s beliefs, assumptions and experiences may influence the 
interpretation of the participant’s account. In order to increase awareness of potential 
sources of bias and the emotional reactions evoked by interview content, the 
researcher completed a reflective log. This enabled the process of ‘bracketing’ 
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perspectives, ideas and expectations throughout the research process (Smith et al., 
2009). Supervision was also used as a space to reflect on the emotional impact of the 
interviews and to facilitate the awareness of possible assumptions or sources of bias. 
Toma (2000) recommends attempting to get as close to the participant’s experience as 
possible in order to enhance understanding of this experience. Research supervision 
was used to help test validity and develop the coherence and plausibility of the 
interpretation. 
Results 
The analysis resulted in the development of three interrelated superordinate themes 
(Table 2). For the purpose of transparency within the analysis these themes are 
presented with participant narratives and substantiating excerpts.  
Table 2: Superordinate and Subordinate themes 
 
Three participants provided insight into what it is like to live with a severe mental 
illness and heart failure. They reflected on difficult life changing experiences, and 
how they believed that these experiences contributed to their illnesses. They 
highlighted the impact these illnesses have had on their lives, for example, the 
Superordinate Subordinate 
 
“It was just so stressful”  
 
Loss/grief 
Being so ill 
Diagnosis 
Cause 
Positioning the illnesses 
 
 
“You’re not the same person that you 
were”  
 
 
Emotional consequences 
Change to lifestyle 
Managing treatment plan 
 
 
“I don’t know what I’d do without 
them”  
 
Lack of support 
Talking helps 
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emotional consequences, changes and limitations, and the role of other people for 
support.  
 “It was just so stressful”  
All participants reflected on their experiences of being ill. They all experienced a life 
changing loss that triggered significant mental health difficulties. They all believed 
that this experience might have, in some way, contributed to the development of HF, 
particularly in relation to the extreme levels of stress they experienced. Getting a 
diagnosis of HF was “a bit of a shock” as they had had no previous knowledge or 
issues related to their heart. They all tried to make sense of what caused the HF, two 
believing they may have caused it. Finally, they all highlighted struggling with the 
emotional consequences of being so ill. 
“When it stopped, it stopped dead” – Loss/grief 
When describing experiences leading up to the development of heart failure all 
participants reflected on their experience of stressful life events. These events 
involved experiences of significant loss and grief and tended to make sense of the 
emergence of their heart failure in this context. When  ack’s mother died he “took it 
quite bad” (Jack, 5.124):  
“When my mother died, I took it quite bad so I did…it made me really 
depressed, I went into a wee depression yeah…I think it was just cause of the 
way she died…I think I was just under a lot of stress an that yeah, yeah a lot of 
things sorta just ganged up on me…“I just locked myself in my room an that, I 
never even came out” (Jack, 29.713-716). 
Mary had suddenly lost her job due to an accident:  
“It was a good job, I enjoyed it, so when it stopped, it stopped dead you know, 
and I couldn’t walk, you know, and I think that’s when I went into a deep 
depression” (Mary, 5.125-126).  
Jane struggled with the unexpected loss of her father: 
“When I lost my Dad it just tore the heart out of everyone…that was just 
horrible…I just took on too much and that’s how I became to have mental 
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illness…I took a breakdown and I was hospitalised for three and a half 
months” (Jane, 7.192-193). 
 “I can’t go on like this” – Being so ill 
Before being taken into hospital and diagnosed with HF, all participants had been 
going through what could be described as a crisis, and these experiences seemed to be 
important in participants making sense of the timing of their HF. Mary had recently 
moved house, and had started to hear voices. 
“I’d just moved into a new house {okay} and the whole upheaval of moving, I 
think it took a lot out of me and when I moved into the house I started to hear 
voices {okay} and I became frightened because I thought the voices were 
real…and it just got to the stage, it must’ve been it just got all too much and I 
ended up having a heart attack” (Mary, 2.41-44). 
In addition to still grieving the loss of his mother, Jack had also been struggling with 
his physical health for a long time:  
“I had this persistent cough for a long while couldn’t get rid of it…and then 
one day I woke up I was very badly swollen…my legs and feet were all inflated 
an that and I could barely breath…I went down to the hospital, the accident 
and emergency and I got taken in” (Jack, 1.5-10).   
Jane had been suffering with asthma for months. She had been to hospital on two 
previous occasions. On the third occasion she was diagnosed with HF. Before being 
given the diagnosis, she described feeling like she couldn’t go on: 
“I thought oh my God please I can’t go on like this, and at that time I was 
annoyed and I thought, I need to know what’s going on I’ve had enough I need 
to know what’s going on I’m gonna end up, it’s gonna kill me. There’s nothing 
worse than when you’re fighting to breathe and you think your hearts just 
gonna stop…”(Jane, 3.62-64). 
“It was a bit of a shock right enough” – Diagnosis 
  
 
49 
The diagnosis of HF was unexpected, and a significant life-changing event associated 
with a range of intense emotions. When given the diagnosis of HF, and when they 
realised the severity of their illness, the main emotion described was fear: 
Jack: It was a bit of a fright yeah…you’ve got heart failure its like, it’s 
frightening yes (Jack, 2.27). 
Mary: “I got such a fright with the heart attack, and I believe the doctor saved 
me, and next time he might not have been able to help me” (Mary, 17.435). 
As mentioned above, Jane spent months thinking she had bad asthma. When she 
finally received a diagnosis of HF and started on appropriate medication she described 
initially feeling relief: 
“I got my diagnosis the third time, and what a relief, such a relief to get 
diagnosis and get put on medication…it was like a wonder pill, I was like oh 
my God, it was just so…my breathing, it was an instant relief, just an instant 
relief” (Jane, 3.68-69). 
It was only after Jane got discharged back home when the reality of her diagnosis 
sank in: 
“I thought oh god I’ve got a heart condition, that’s, that’s scary, I’ve got a 
heart that’s impaired, that’s not working properly and I, I could die, and, took 
me really, to get my head around” (Jane, 3.87-88). 
“I brought it all on myself” – Cause 
There was a process of trying to come to terms with the diagnosis, and trying to 
determine what may have caused their HF. On three occasions, Mary explained that 
she believed her levels of distress associated with hearing voices caused her HF: 
“I didn’t realise it at the time what was happening you know {okay} and this 
started because I was so frightened. I actually brought the heart attack on 
myself, you know” (Mary, 1.17-18). 
Jack gave the impression that he was still searching for an answer to what caused his 
HF. He highlighted that “it runs in the family right enough”. Also, that side effects of 
anti-psychotics was one of the “theories” (Jack, 8.187) suggested to “have attributed 
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to the heart failure” (Jack, 8.187). He also expressed on two occasions that he maybe 
“worried too much and brought it on” (Jack, 6.150). On the other hand, Jack talked 
about eating healthy and that he “hadn’t had anything that should cause heart 
failure”, and therefore, he gave the impression that he was still actively making sense 
of “why I had to come down with it” (Jack, 6.39). 
“I don’t think one affects the other” – Positioning the illnesses 
There were important differences in how the participants related their experiences of 
mental and physical health difficulties. This could, in part, be explained by timing of 
the difficulties. Mary believed that her difficulties had “been building up” (Mary, 
4.96), and that the fear she experienced of hearing voices “brought on” (Mary, 1.18) 
a heart attack and subsequent diagnosis of HF. The two events, hearing voices and a 
heart attack, occurred close in time. 
 ack and  ane’s experiences occurred at different times in their lives. The onset of 
their mental health difficulties was in their 20’s, and HF occurred in their 40’s.  ane 
explained that both conditions had “definitely affected my life”. She described living 
with HF to be “very debilitating” but that currently her mental health was “much 
better now” (Jane, 17.478). 
Jack offered a lot of information and insight into his HF, however, when asked about 
his mental health difficulties, he replied, “I don’t like talking about it” (Jack, 7.75). 
He described embarrassment when talking to others about his feelings “I’m a really 
private person” (Jack, 31.769) and that he didn’t like the “stigma of going to see 
psychiatrists and psychologists” ( ack, 32.812). He also explained that he didn’t feel 
that “one affects the other“ (Jack, 15.76) in relation to physical and mental health. 
However, as mentioned above, when trying to determine the cause of his HF, he did 
make links with his antipsychotic medication and also between how stressed and 
depressed he had been feeling before he was diagnosed with HF.  
“You’re not the same person that you were”  
Participants described many changes to their lives as a consequence of their illnesses.  
They described fears, worries, uncertainty about the future, struggles with managing 
their treatment plan, and important lifestyle changes, for example, changes to diet and 
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exercise, and not going out as much as they used to. They all described feeling limited 
or restricted by their illnesses. 
“I worry about this and I worry about that”  - Emotional consequences 
Anxiety, and a sense of feeling daunted by their illnesses was apparent for the 
participants. Much of this anxiety was related to having a heart attack or dying young:  
Jack: “I’m just worried in case (pause) maybe doing too much or something 
like that an {okay} might bring on a heart attack or that (laughs) (Jack, 
19.480-481). 
Jane: “I try not to let it get me down, but eh, but it does, it scares me, and I’m 
scared in case I die young from it, and that scares me sometimes (pause) I try 
not to think like that but…I do really worry sometimes, I do really worry 
(Jane, 4.110-112). 
For Mary, rather than worry or fear about something happening physically, she was 
trying to cope with hearing voices on a daily basis, “the problem is the voices, I still 
hear those voices” (Mary, 18.451) which she found “scary, very scary” (Mary, 
19.478) and it was these voices that she saw as causal to her HF. 
“I don’t venture out too much now” – Changes to lifestyle 
These intense worries impacted the participants’ quality of life: 
Jack: “I think coz I’m worried in case something happens to me yeah…yeah 
even walking down a flight of stairs I’m always thinking about things like that 
an so I don’t come out so much now an that, try to stay in quite a lot now, I 
don’t venture out too much now yeah” (Jack, 19.459-463). 
Jane described changes as a result of her illnesses as life restricting: 
“It’s (pause) it’s life restricting (pause). I used to love walking (pause) can’t 
do that anymore…”(Jane, 4.109). 
Jane also described a desire to do more as she felt this would help with her health, but 
felt worried about something happening: 
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“I would love to eh I really would but eh just at the minute I worry in case I do 
exercise now and something happens” (Jane, 15.443). 
For Mary, she used to feel very capable and organised, and now felt dependant on 
everything. These feelings impacted her life, and given the number of pauses she took 
to explain this, possibly highlighted the emotional significance for her:  
Mary: “ I used to be an avid reader but I can barely be bothered to read 
anything you know…I don’t have the concentration…I used to be quite an 
organised person ehh, very capable but I’ve went from one extreme to the 
other whereas I’m dependant on everything, you know”. 
Interviewer: “And how does that make you feel?” 
Mary: “Pretty crummy (laugh) it’s the only way I can describe it, ehh, you’re 
not the person that you were (pause) well I’m not (pause) I used to be out and 
about, good source of life and (pause) had a good job and I lost everything 
you know (pause) feel as if I’ve lost ma identity…(Mary, 15.381-390). 
 
“It’s a bit of a nuisance actually” – Managing treatment plan 
All three participants commented on healthcare staff and how they “never says what I 
shouldn’t do or what I should do…eh they just eh, keep onto my medication an that” 
(Jack, 4.93). In relation to medication, they all talked about the number of medications 
they are required to take and how they sometimes forget to take them: 
Jane: “I make sure to take my medication regularly which I do do, there’s a 
couple of days here or there I won’t, I’ll miss a dose but I think that’s quite 
normal I know I shouldn’t but I do” (Jane, 13.385-386). 
For Mary, she was finding managing her medications difficult, to the extent she 
required support from the pharmacy: 
Mary: “Well at first I was getting it all mixed up, then they organised me a 
blister pack and that makes it a lot easier ya know”. 
Interviewer: “Okay, who organised that for you?” 
Mary: ”The chemist”. 
Interviewer: “And how was that for you?” 
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Mary: “Good, definitely a lot better (pause) coz I was getting all my 
medication at the same time and I was running out, and I was forgetting to 
order something and I didn’t realise I was so low in something and I would 
run out” (Mary, 13.329-345). 
 
Jack also forgot to take his medication sometimes and described his medication plan 
as “a bit of a nuisance actually” (Jack, 12.293). Unlike the other participants, Jack 
discussed issues he had with medications. He felt anxiety around taking medication 
because he didn’t like tablets that “mucks around with the heart” (Jack, 22.536), and 
said that he’d rather not know what they do and just take them.  
“I don’t know what I’d do without them” – Role of others 
The value of others was something that was highlighted by all three participants. 
Unfortunately for Jack, his mother was the only person in his life so when she died it 
“took the fun out of everything”, ( ack, 29.735) and he didn’t have anyone else. For 
Mary and Jane, they had family who helped with their mood, alleviating worries and 
providing reassurance. For the most part, support from health care staff was viewed as 
positive, however, they all experienced, to some degree, a lack of support, a lack of 
understanding, and a lack of shared decision making about their care. 
“Nobody ever told me what to do” – Lack of support 
All three participants described the support they received from healthcare 
professionals. For the most part, participants described the care and support as being 
positive, however, all three also described a lack of adequate support or information at 
some point or another during their time involved with services. Jane was positive 
about her support from cardiac professionals. She also described getting taken care of 
when she was in psychiatric inpatient care but then “they decide she’s fine to get out” 
(Jane, 8.236) and that “you come out and it’s just boom” (Jane, 9.242). She explained 
that it’s “absolutely crazy because that’s when the depression starts” (Jane, 8.236). 
These statements suggested that  ane didn’t feel she received an appropriate level of 
support following discharge. Her statement “they decide she’s fine to get out” was 
striking, implying a lack of involvement in decision-making.  
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As mentioned earlier, in relation to medication, both Mary and Jack described not 
being given enough information about how to take their medication. Mary explained, 
“nobody ever told me what to do” (Mary, 13.319). Jack described feelings related to 
anxiety regarding information on medication, explaining that he felt it was 
“irresponsible” to prescribe medication without giving out information on side 
effects.  When asked if he’d been given information he said that a “nurse did run over 
it with me” (Jack, 14.338), however, the use of the word “run” suggests he may have 
felt that the information was given too quickly, and that maybe he feels that not 
enough time was spent going through this information. Jack highlighted that one of 
the “avenues” that healthcare professionals had considered was that the anti-
psychotic he had been taking for a long time may have caused his HF, thus, it was 
understandable that he may have felt that they “could better explain that type of 
medication” and why his concern about side effects “puts the fear of death in you” 
(Jack, 9.234).  
“I’ll always be indebted to my mum” – Talking helps 
Both Mary and Jane described the importance of having others around to support 
them, both practically and emotionally. It was helpful to have professionals to talk to 
and provide reassurance, “I could talk to her (CPN) about anything and she was such 
a good listener and she reassured me” (Jane, 9.257). Mary also had family who 
visited and spent time with her: 
“That’s nice that somebody’s taken the time out to do that you know, as I 
mighta been sitting in that day, feeling low, and he’s cheered me up (Mary, 
23.571-572).  
In contrast with Mary and Jane, Jack described himself as a “very private person” 
( ack, 10.246), and that he didn’t “find it easy to talk to people”  (Jack, 10.239). He 
also felt that he didn’t see “how anybody else would be able to help me in that way” 
( ack, 18.437).  ack explained that he didn’t have any other family, that he only had 
his mother, and that he took his mother’s death “quite bad” (Jack, 5.124).  
Discussion 
This qualitative study explored the experiences of people living with a severe mental 
illness and heart failure. Specifically, it examined how they made sense of what it was 
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like to live with two severe illnesses, what they find difficult about their illnesses, and 
what helps them to cope with and manage their illnesses. Three main themes were 
identified from the participants’ accounts. These themes were focused on the 
experience and stresses associated with being ill, changes and adjustments that were 
made as a result of being ill, and the role of others in helping to manage their 
illnesses. While these three themes are presented separately, they were inter-related, 
particularly the emotions experienced by participants across all three themes. 
All three individuals in this study had experienced a significant loss in their life. They 
all identified being unable to cope with the intense emotions and distress, therefore, 
making them vulnerable to a significant period of mental ill health. They all attempted 
to process and make sense of these experiences. One participant believed her mental 
ill health caused her HF. For the other two participants, they did not explicitly link 
their mental ill health and physical ill health. However, in the process of trying to 
make sense of why they developed HF, both had questioned whether extreme levels 
of stress could cause the onset of HF. As such, for these participants, the onset or 
development of their HF may best be understood in the context of their experience of 
significant life events and associated levels of distress.  
Receiving a diagnosis of HF was understandably frightening for all three participants. 
The worry and fear associated with the uncertainty of their cardiac symptoms was 
alleviated somewhat by the diagnosis of HF. However, the anxiety and fear of 
something happening in the future was a current and persistent characteristic for all 
participants. For example, a fear of dying young, constant worrying about having a 
heart attack, or a fear of the voices returning. Related to this were the behavioural 
changes that all three participants described. They were conscious of the fact that in 
some way, the change was associated with low mood or anxiety, rather than physical 
limitations related to their HF. They highlighted not feeling motivated to do things, or 
purposefully avoiding things they used to do, for fear of something happening, 
whether it be a physical event, such as a heart attack, or an escalation in voice hearing. 
There was, however, a desire to do more, to get back to doing some of the things they 
used to do and enjoy. This finding echoes results by Thornhill, Lyons, Nouwen and 
Lip (2008), which explored people’s experiences of living with HF and also found 
that people expressed a desire to get back to doing things they enjoy doing. 
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The study highlighted the value that participants placed on others, both professionals 
and family members, to support them with recovery and adjusting to their illnesses. 
The findings provided specific examples of what participants needed and valued from 
other people. Firstly, practical support was highlighted, in particular, support with 
medication management. All three participants described difficulties with this and one 
participant highlighted that support from a pharmacist resolved difficulties with 
managing medication. This finding supports research focused on the role of the 
pharmacist for improving treatment adherence (Murray, Young, Hope, Tu et al., 2007; 
Parajuli, Franzon, McKinnon, Shakib et al., 2017). Secondly, an awareness of 
psychological distress and offering emotional support was identified as valuable. This 
helped to alleviate emotional distress and worries, provide reassurance and lift mood. 
Therefore, provision of psychological support may help people adapt to and manage 
their health better. Research has shown that failure to do so can result in poorer 
outcomes and faster disease progression (de Ridder, Geenan, Kuijer & van 
Middendorp, 2008).  
What was apparent for all three participants was how they provided a rich insight into 
their lives and their experiences of two severe illnesses, including how they conveyed 
the day-to-day struggles that they faced. What emerged from these accounts was a 
portrayal of resilience, determination and an ability to cope with significant life 
changes. Unlike previous research that suggests that people with HF and people with 
a SMI struggle to adhere to their treatment plan (Cole et al., 2006; Gilmer et al., 2004; 
Owen-Smith et al., 2016), the participants in this study appeared to meet the 
challenges of managing the complex demands of managing two difficult and life 
changing conditions. They were also attending their routine appointments with both 
physical and mental health clinicians. They did explain some lifestyle changes, such 
as avoiding going out, however, they all expressed a desire to do more and they did 
not engage in many of the poor lifestyle behaviours that research suggests people with 
a SMI are more likely to engage with (Meyer, 2001; Ringen et al., 2014; Shulman et 
al., 2014). 
Methodological Strengths and limitations 
We aimed to identify a homogeneous sample of individuals with an SMI who had 
experienced heart failure and were under follow-up from Cardiology services. 
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Recruitment efforts were significant in terms of screening caseloads of busy 
cardiology clinicians and also undertaking an independent data linkage. These data 
had not previously been linked and a number of important governance permissions 
needed to be established in order to receive permission from the Caldicott Guardian. 
Our final sample of three participants is small but within guidelines for IPA. As a 
result we ensured that our analytical approach had a depth of commitment to the 
idiographic nature of IPA through the development of within transcript coding and 
individual case studies. During the coding process we actively sought to identify data 
that had not been captured during the initial coding processes and this enabled us to 
challenge and elaborate emerging codes and themes. Only when we had fully 
saturated data within an individual transcript did we seek to compare and contrast 
across transcripts. Although a general limitation of qualitative methods is the 
influence of subjectivity, interpretation and bias, we ensured that the researcher 
completed a reflective log throughout the process and received regular supervision 
where their own assumptions and interpretations of the data were actively explored 
and contested. In addition, a check of validity was conducted by the research 
supervisor. It is important to note that the inclusion criteria for the study may have 
influenced recruiting individuals who were successfully negotiating two complex 
conditions, therefore, excluding individuals who may be finding this difficult. 
Implications for clinical practice 
The study demonstrated that participants were managing the demands of two severe 
illnesses and that participants were able to provide a good insight into their health and 
into the care they received from services. They were able to identify gaps in service 
provision that could better equip them with the knowledge and skills to manage their 
physical and mental health needs and support them to achieve a healthier and more 
fulfilling lifestyle. For example, extra support with medication, guidance on how 
much exercise participants can safely do, and emotional support. By including service 
users in the content design and delivery of a package of care, it could help to ensure 
that people managing two severe illnesses are receiving the appropriate care. It may 
also encourage better self-care behaviours. Research suggests that if patients are 
supported to manage medication and supported with self-care behaviours, they are 
better able to manage their illnesses (Koshman et al., 2008; Parajuli et al., 2017; 
Riegel et al., 2011). 
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There is an increasing evidence base that focuses on the relationship between mental 
and physical health, in particular, how the current NHS system identifies and provides 
access to appropriate treatment for people living with both physical and mental health 
needs (The King’s Fund; Attar,  ohansen, Valentin, Aagaard et al., 2017; McLean et 
al., 2013; Smith et al., 2013). This study highlighted the disconnection between 
physical and mental health care needs. For example, this study originally aimed to 
recruit through liaising with the cardiac teams. However, clarifying a mental health 
diagnosis from physical health notes was difficult, for example, the anti-psychotic 
medication, clozapine, is not routinely recorded in physical health notes. Often, 
nursing staff lacked information regarding a mental health diagnosis. As a result, data 
linkage was required to try to overcome this issue. The significant effort required to 
recruit participants highlighted a lack of integration between physical and mental 
health care, and supports and strengthens current health specifications and drivers for 
integrating physical and mental health care (The King’s Fund).  
Future research 
Qualitative methods such as IPA can play an important role in uncovering important 
experiences that contribute to how people navigate their pathway through the NHS. 
Understanding these experiences have a powerful role to play in designing services 
that are focussed on and responsive to users’ mental and physical health needs. 
Recruitment highlighted a lack of integration between mental health and physical 
health services and the impact of this lack of integration was evident in the 
experiences and meanings identified in this study. Further research broadening the 
scope into other cardiovascular problems is important, incorporating the views of 
those with a lived experience of both SMI and cardiovascular problems is merited. 
Research focussing on a broader range of perspectives, at different points in the care 
pathway in both mental and cardiovascular services could be valuable in helping 
improve services design, for example, in the content design and delivery of self-
management interventions. In addition, participants in this study described important 
emotional needs in relation to adaptation to their HF and further research is merited to 
explore whether these needs could be addressed by psychological interventions to 
enhance recovery and adaptation. Finally, given the inclusion and exclusion criteria, 
people functioning at a lower level were likely to have been excluded from this study. 
Future research should attempt to engage this population, not only to understand their 
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lived experiences, but ideally, also as co-producers and collaborators in the research 
and design of service delivery.  
Conclusion 
This is the first study of its kind that we are aware of to examine the experiences of 
people living with both a severe mental illness and heart failure. The results 
highlighted difficult life experiences for every participant, and offered insight into the 
impact of these experiences. It demonstrated a process of trying to make sense of and 
come to terms with these experiences. Change was apparent for all participants, 
specifically, adhering to a lot of medication, not feeling able to do things they used to 
do, and having to live with, on a daily basis, the fear and worry that is brought about 
by living with a SMI and HF. The study highlighted the role of others, suggesting 
times when the level of care may have fallen short, and the type of support, mainly 
emotional support, that participants found to be most helpful. Finally, the study 
demonstrated that participants were able offer a good insight into their experiences, 
show good compliance, resilience and determination in the face of day-to-day 
challenges associated with two severe illnesses. 
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Background 
People living with a severe and enduring mental illness are at greater risk of 
developing heart failure (HF) than the general population (Blom, Cohen, Seldenrijk et 
al., 2014). This is due to the risks associated with antipsychotic medication and health 
behaviour risks, such as poor diet, lack of exercise, smoking, use of alcohol etc. 
Nonadherence to treatment regimens is common for people who have a severe mental 
illness, and also people with HF. Thus, nonadherence is likely to be an issue for 
people with comorbid mental illness and HF. At present little is known about the 
experience of people with both of these illnesses, and the factors which influence 
adherence to their treatment regimen. 
Aims 
The aim of the current study is to describe the experience of people with severe 
mental illness and HF. Specifically, to determine patients’ understanding of their 
condition and the factors influencing treatment adherence.  
Methods 
This qualitative study will recruit between 5-10 participants. Their interviews will be 
analysed using Interpretative Phenomenological Analysis.  
Applications 
It is hoped that this study will help provide a dialogue to aid our understanding of 
patients’ experience of their comorbid illness, and the factors associated with 
adherence to treatment regimens. 
 
Introduction 
Heart failure occurs when the heart fails to pump blood around the body as effectively 
as it used to (The British Heart Foundation (BHF)). There are over half a million 
people in the UK living with heart failure (HF). The most common causes of HF are a 
heart attack, high blood pressure and diseases of the heart muscle, known as 
cardiomyopathy. People who experience severe and enduring mental health problems 
such as, psychosis, schizophrenia and bipolar disorder, are at greater risk of 
developing serious heart problems like HF, compared to the general population 
(Blom, Cohen, Seldenrijk et al., 2014; Correll & Nielson, 2010; Laursen, Munk-Olsen 
& Vestergaard, 2012; Nielson, 2011; Ifteni, Correll, Burtea et al., 2014). This is in 
part due to the risks associated with prescribed antipsychotic medication and also 
behavioural health risks such as poor dietary habits, smoking, use of alcohol, obesity, 
living a sedentary lifestyle etc. (Shulman, Miller, Misher & Tentler, 2014). 
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Adherence to a treatment regimen 
Adherence has been defined as the “active, voluntary, and collaborative involvement 
of the patient in a mutually acceptable course of behaviour to produce a therapeutic 
result” (Ho, Bryson & Rumsfeld, 2009). Virtually all health treatments require some 
degree of behaviour change on the part of the patient (Levensky & O’Donohue, 
2006). This may involve behaviours such as, engaging in regular exercise, following a 
diet, smoking cessation, attending clinic appointments, adhering to medication etc. 
Making these changes may be inconvenient, require a lot of effort and cost, and cause 
adverse effects. These issues may lead to low adherence or nonadherence. Low or 
nonadherence to treatment plans can take many forms: attending appointments late or 
not attending appointments at all, not taking medication or taking medication 
incorrectly (too few, or too many pills), not initiating the treatment regimen or ending 
the treatment regimen prematurely.  
Nonadherence to treatment plans is a growing concern for clinicians and health care 
providers (Ho et al., 2009). There are substantial health, social and financial costs 
associated with nonadherence (Levensky & O’Donohue, 2006). For example, for the 
patient, nonadherence compromises the effectiveness of the available treatment, it 
increases the risk of relapse, it interferes with recovery, it can lead to hospitalisation 
and in many cases, it can lead to death (De las Cuevas, Penate & Cabrera, 2016; 
Owen-Smith, Stewart, Green, Ahmedani et al., 2016). For the physician and 
healthcare system, nonadherence questions the effectiveness of the treatment 
recommendations, and it increases costs, such as costs associated with patient relapse 
and hospitalisation etc.  
Even in ordinary circumstances, adherence can be difficult to maintain (Prochaska, 
DiClemente & Norcross, 1992). It is not surprising then that for people with chronic 
and multifaceted illnesses, adherence may be somewhat complex. People with a 
severe psychiatric disorder (psychosis, schizophrenia, bipolar disorder) and HF are 
prescribed medications for their illness (an antipsychotic such as clozapine), and they 
are likely to have been prescribed a range of medications for their heart, in many 
cases two to three different types. In addition to this, it is most likely that they will be 
advised to make some lifestyle changes such as engaging in some form of exercise, 
stopping smoking and changing their dietary habits (BHF). The extent to which these 
patients adhere to their medication regimen and follow the advice provided is 
currently unknown. However, research has shown that medication nonadherence is 
common in patients with schizophrenia (Gilmer, Dolder, Lacro, Folsom et al., 2004; 
Haddad, Brain & Scott, 2014; Nelson, Graham, Lindsey & Rasu, 2011; Owen-Smith 
et al., 2016) as well as in patients with HF (Chin & Goldman, 1997; Cole, Norman, 
Weatherby et al., 2006). Factors such as: illness severity, treatment complexity, cost, 
lack of illness awareness, social isolation, comorbid substance misuse, stigma and 
poor access to appropriate medical care (Hadded, Brain & Scott, 2014; McDonald, 
 arg & Haynes, 2002; Santiago, 2016) all impact a patient’s ability to comply with 
their treatment plan.  
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Determinants of adherence 
Understanding and addressing adherence difficulties is crucial for improving patient 
care, improving outcomes and lowering treatment costs (Haynes, McDonald, Gang & 
Montague, 2002). Research into adherence has identified common factors/themes that 
may predict whether a person will adhere to their treatment regimen. For example, 
one factor identified is in relation to the treatment itself: the complexity of the 
treatment regimen to be followed, the cost required to adhere to the treatment. If the 
treatment is complex and costly, patients are less likely to adhere. Sociodemographic 
factors have also been found to negatively impact patient adherence, for example, lack 
of a good support system, high level of social deprivation.  
Perhaps the most extensively researched factors are patient-related factors, such as, a 
patient’s personality, their beliefs, motivation, self-efficacy, or whether they are 
depressed. These are all factors that have been shown to impact a patient’s level of 
adherence (Christensen, 2004). These different characteristics and health beliefs have 
been integrated into structured models, which attempt to predict health beliefs and 
health behaviours. The Health Belief Model (Becker & Rosenstock, 1987), Self 
Determination Theory (Deci & Ryan, 2000) and Stages of Change Model (Prochaska 
& DiClemente, 1986) are examples of models that have been developed to understand 
and predict health beliefs and health behaviours. However, reviews of the literature 
have generally concluded that there is little or no association between patients’ beliefs 
identified in the above models, and adherence to treatment (Christensen & Johnson, 
2002; Dunbar-Jacob & Schlenk, 2001). Furthermore, there is little evidence to suggest 
that other factors, such as personality traits and sociodemographic factors are also 
related to adherence (Christensen & Johnson, 2002; Dunbar-Jacob & Schlenk, 2001).  
Christensen and colleagues (2002; 2004), (based on research by Higgins, 1990), 
suggest that attempts to identify traits or dispositions that predict behaviour are of 
limited usefulness without also considering the context, or situation, that an individual 
is facing. Instead, they consider the joint or interactive effects of patient/characteristic 
factors along with the context of the treatment regimen (severity of the illness, type of 
treatment) (Christensen, 2004). From this perspective, it is the interactive effect of 
patient factors and contextual factors that most strongly influences behaviour 
(Christen & Johnson, 2002). For example, research has shown that individuals who 
have more active coping styles show a better response to treatment that is under their 
control (doing exercise, taking medication at home) rather than under the control of 
the therapist (e.g. treatment administered in hospital). In contrast, patients who tend to 
show a less active coping style, or who disengage from stressful situations tend to 
show better adherence when the treatment is therapist led (Dance & Neufeld, 1988; 
Christensen, Smith, Turner & Cundick, 1994). By gaining an understanding of the 
interaction between a patient’s traits, beliefs, coping styles and the type of treatment 
they are undergoing, interventions can be tailored appropriately, increasing the 
likelihood of good adherence to the treatment plan. 
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Managing severe mental illness and heart failure 
Factors found to negatively impact adherence for someone with a severe and enduring 
mental illness are: patient-related factors such as attitudes and past behaviours, 
comorbid conditions, symptom severity, medication-related factors, and 
environmental factors (Velligan, Weiden, Sajatovic, Scott et al., 2009). Similarly, 
factors found to negatively impact adherence for someone with HF are: patient-related 
factors such as depression and anxiety, comorbid conditions, and problems with the 
health-care system (Riegel et al., 2009). Patients facing at least one of these illnesses 
have been found to struggle to adhere to their treatment plans, and effort has been 
made to understand and address this (Loffler, Kilian, Toumi & Angermeyer, 2003; 
Marder, Essock & Miller et al., 2004; Nielson, 2011; Riegel & Carlson, 2002; Riegel, 
Moser, Anker et al., 2009; Saha, Chant & McGrath, 2007). Many of the factors found 
to impact adherence in one of these serious illnesses is likely to affect someone who 
experiences both serious illnesses. However, at present, the extent of this is unknown. 
As the risks are even greater for these patients, it is essential that research is 
conducted to determine their experience of their illness, to understand the factors 
influencing nonadherence which in turn should help guide the best treatment regimen.  
Positioning the study 
Interpretative Phenomenological Analysis (IPA) is a qualitative research method, 
which explores the idiographic subjective experiences of individuals, how they 
ascribe meaning to their experiences and how they make sense of their world 
(Biggerstaff & Thompson, 2008). Through reflective interpretation, the researcher 
becomes an active agent in the lived experiences of the participants (Braun & Clark, 
2013; Smith & Osborn, 2008). 
This seminal study will be the first to explore the experiences for people with both 
severe mental illness and HF, and hopes to inform the literature base about this 
otherwise previously unknown topic.  
Aim 
The aim of the current study is to describe the experience of people with severe 
mental illness and HF. Specifically, to determine patients’ understanding of their 
condition and the factors influencing treatment adherence.  
Method 
Design 
This study utilised Interpretative Phenomenological Analysis (IPA). IPA explores 
how individuals make sense of their social world, with a focus on finding the 
meanings that are attached to specific experiences (Smith & Osborn, 2008). IPA has 
roots in epistemology while also focussing upon 1) phenomenology, a philosophical 
approach concerned with lived experience 2) double hermeneutics, whereby the 
researcher attempts to make sense of the individual who is making sense of their own 
  125 
experiences 3) idiographic in-depth exploration of individual cases (Smith, Flowers & 
Larkin, 2009). In accordance with IPA methodology, purposive homogeneous 
sampling was utilised such that participants were selected due to their experiences of 
living with both a diagnosis of a severe mental health difficulty and a diagnosis of HF, 
and the in depth insight they can provide in to these experiences. 
Participants 
Participants were English speaking patients, over the age of 18, who were diagnosed 
and receiving treatment for HF and had a recorded and/or patient reported diagnosis 
of schizophrenia, psychosis or bipolar disorder. They were prescribed either a mood 
stabiliser (lithium) or an anti-psychotic (e.g. clozapine, olanzapine, risperidone, 
quetiapine) to treat their mental illness. They were judged to be in a stable condition 
(based on clinical judgement of the clinical team in the first instance, and then by 
researcher’s clinical judgement at initial telephone contact, and on day of interview) 
with no coexisting medical comorbidity. Potential participants were excluded if they 
had a diagnosed learning disability, cognitive impairment, or were currently unstable 
(e.g. psychiatric hospitalisation within the last 6 months). Those who were not 
competent in understanding questions in English were also excluded. A total of six 
potential participants were identified but excluded. One person was receiving 
palliative care, one had recently been admitted to hospital, two were cognitively 
impaired and two were judged by the clinical team to be too unwell to participate. 
Five potential participants who met inclusion criteria were identified. One potential 
participant DNA’d his appointment and, as a result, could not be recruited within the 
study timeframe. The second potential participant decided he did not wish to 
participate in the study.  
Procedure 
Prior to commencing recruitment, ethical approval was obtained from the East 
of Scotland Research Ethics Committee (Appendix…) Research and Development 
Management Approval was obtained for NHS   C (Appendix…), and Caldicott 
guardian approval from NHS GGC was obtained (Appendix…). Recruitment took 
place between October and March 2018. There were two methods of recruitment. The 
first method was via consultation with staff from the cardiology teams throughout 
NHS GGC. HF nurses, pharmacists and cardiologists were provided with standard 
information leaflets and were asked to consider, in collaboration with researcher, 
patients on their caseload who may be eligible for inclusion in the study. The second 
method involved obtaining patient CHI numbers from databases to match up patients 
who have HF and who are taking anti-psychotic medication. A list of HF patient CHI 
numbers will be obtained from each HF team. A list of patients who are on 
antipsychotic medication will be obtained from the Psychological Clinical 
Information System (PysCIS database, NHS GGC). The CHI numbers will be 
transferred onto one database and matching CHI numbers will be identified. 
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Researcher will then contact the HF team, highlighting the CHI number (at this stage 
no other identifying information will be given to researcher). Researcher and HF 
nurse/cardiologist will discuss eligibility for the study. Approval from NHS GGC 
Caldicott Guardian will be sought and all data collected will be stored on a NHS 
computer and password protected, only accessible to the principle researcher. 
Participants were informed about the study via carer groups and staff of NHS 
Lanarkshire’s Forensic Mental Health Service, as well as Support in Mind Scotland. 
Staff were given information about the study (Appendix 7) and recruitment posters 
were placed in forensic mental health service venues (Appendix 8). Staff were 
encouraged to identify suitable participants and provide them with the Participant 
Information Sheet (PIS) (Appendix 6). In addition, with permission the researcher 
visited the NHS Lanarkshire forensic carers group and delivered a short presentation 
about the study. The PIS containing the contact details of the researcher was left for 
those interested in finding out more about the study. Those interested were asked to 
provide contact details to a staff member which were then returned to the researcher. 
The researcher then contacted the person to answer any questions and establish if they 
wished 
to participate. Following this, an interview was arranged for those who agreed to 
participate. Written informed consent was obtained prior to commencing the 
interviews (Appendix 9). Interviews were held in clinic rooms of local NHS venues. 
Methods 
A semi-structured interview guide was developed to address the main research aim 
and according to IPA guidelines (Smith, Flowers & Larkin, 2009). The suitability of 
this guide was discussed and developed with the research and field supervisor. Expert 
clinicians working with patients with HF were also consulted for guidance. A pilot 
interview was conducted in order to ensure the interview is feasible, and to determine 
any risk factors. Interviews were approximately one hour in duration. 
Participants 
Three participants were recruited for the study. These patients were receiving 
treatment for HF and on antipsychotic medication to treat their mental illness. The 
study included both males and females, over the age of 18. Socio-demographic 
information such as age of participant, diagnosis, occupation and postcode was also 
gathered. 
Inclusion and Exclusion criteria 
People will be eligible to participate if they are aged 18 years and over, have had a 
diagnosis of HF for at least one year, and have a recorded and/or patient reported 
diagnosis of schizophrenia, psychosis or bipolar disorder. Participants will have been 
prescribed a mood stabiliser (lithium) or an anti-psychotic (e.g. clozapine, olanzapine, 
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risperidone, quetiapine) as well as medication related to HF. They must be in a stable 
condition (based on clinical judgement of the clinical team in the first instance, and 
then by researcher’s clinical judgement at initial telephone contact, and on day of 
interview) with no coexisting medical comorbidity. 
To safeguard against risk, participants will be excluded if they have a diagnosed 
learning disability, cognitive impairment, or are currently unstable (e.g. psychiatric 
hospitalisation within the last 6 months). Those who are not competent in 
understanding questions in English will also be excluded. 
Recruitment Procedures 
It is proposed that there may be two methods of recruitment for the study. The first 
method will occur through consultation with HF nursing staff and cardiologists 
throughout NHS GGC. Researcher will liaise with HF nursing staff and cardiologists 
to explain the nature of the project, the eligibility criteria and also to get a sense of 
potential recruitment numbers. HF nurses and cardiologists will be provided with 
standard information leaflets. HF nurses and cardiologists will be asked to consider 
patients on their caseload who may be eligible for inclusion in the study. Researcher 
will collaborate with nurses and cardiologists to identify patients who meet the criteria 
for the study.  (i.e. over 18, prescribed anti-psychotic medication, clinical judgement 
from clinical team that patient is physically and mentally stable). At this stage, no 
patient identifiable information will be available to researcher.  
The second method involves obtaining patient CHI numbers from databases to match 
up patients who have HF and who are taking anti-psychotic medication. A list of HF 
patient CHI numbers will be obtained from each HF team. A list of patients who are 
on antipsychotic medication will be obtained from the Psychological Clinical 
Information System (PysCIS database, NHS GGC). The CHI numbers will be 
transferred onto one database and matching CHI numbers will be identified. 
Researcher will then contact the HF team, highlighting the CHI number (at this stage 
no other identifying information will be given to researcher). Researcher and HF 
nurse/cardiologist will discuss eligibility for the study. Approval from NHS GGC 
Caldicott Guardian will be sought and all data collected will be stored on a NHS 
computer and password protected, only accessible to the principle researcher.  
Once identified, and agreed upon via consultation with the nurse, researcher and 
supervisors, the researcher will take note of next clinic appointment, and will remind 
nurse leading up to the appointment date, so that nurse remembers to pass on study 
details to their patient. During the clinic appointment, nurse/cardiologist will outline 
details of the study, and information sheets will be provided, to be given to potential 
participants. Nurse/cardiologist will let their patients know that they can contact the 
researcher to discuss the study (contact details provided on information sheet). Also, 
researcher will be available during clinic time (in another clinic room) so that if 
patient does want to discuss study, or has any questions, then researcher can be made 
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available for this. At this stage, there will be no attempt to obtain consent for the 
study.  
At this clinic appointment: if the person decides they wish to participate, they let their 
nurse/cardiologist know who will then inform the researcher, passing on contact 
details. The researcher will contact potential participant via telephone. During this 
initial telephone call the researcher will remind potential participant about the details 
of the study and the fact that participation is voluntary. A pre-screen will be 
conducted to determine current mental state and overall wellbeing, to determine if 
person is still eligible to go ahead with the study. They will also be asked to report on 
their mental health diagnosis (as it may not be clear in medical notes). They will be 
informed that a letter will be sent to their GP and nurse/cardiologist to make them 
aware that their patient is participating in the study. Following this, and if clinically 
judged by researcher to be stable, an interview will be arranged. 
At the interview, if potential participants are still keen to participate, written consent 
will be obtained. It will be explained that all details from the interview, and responses 
of the participant will be anonymised. At this stage, interview will only be conducted 
if participant is clinically judged by researcher to be currently mentally stable to do 
the interview. 
Timeline of recruitment pathway: 
1. Researcher liaises with clinical team to identify potential eligible participants. 
Also, a search of HF CHI numbers and PsyCIS database CHI numbers will be 
completed to identify any matches. If patient/s identified from the database, 
researcher will then contact HF nurse to discuss eligibility. At this stage, 
researcher will only have access to CHI numbers, no other patient identifiable 
information will be given). 
2. Researcher takes note of next clinic appointment with patient (again researcher 
only has access to patient’s CHI number at this stage).  
3. At next clinic appointment, nurse/cardiologist provides details of study, gives 
information sheet etc. Researcher will be available in another room if patient 
has any questions they would like answered. 
4. If verbal consent is given at this appointment, researcher will then contact 
patient via telephone (at least 24 hours later), remind of study, do pre-screen to 
assess stability, and arrange interview time, if eligible. 
5. Interview to be conducted if participant is judged by researcher to be in a 
stable condition. 
 
Data Analysis 
The data will be transcribed verbatim by the researcher. Data will be analysed using 
IPA. Guidelines for analysis as described by Smith, Flowers and Larkin (pp. 79- 108, 
2009) will be adhered to. The stages of analysis are as follows: 
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1. Initial transcription. Close reading and re-reading of the text, noting thoughts, 
reflections and observations that occur.  
2. Interview themes are identified, capturing the essential qualities of the 
interview. Psychological terms and concepts may be used at this stage (Willig, 
2008). 
3. Related themes are developed into clusters or concepts and subordinate 
categories are identified. 
4. The process is repeated for all transcripts, maintaining a willingness to engage 
with new themes that may emerge. 
5. A ‘master’ list, or summary table of themes is compiled. 
 
Justification of sample size 
A sample size between five and 10 will be sought. It has been suggested that fewer 
participants examined at a greater depth is preferable (Hefferon & Gil-Rodriguez, 
2011).  
Settings and equipment 
Interviews will be conducted in a hospital clinic or, if possible, a GP surgery that is 
convenient for the participant. Each interview will be conducted in a quiet room with 
the researcher and participant. All interviews will be audio recorded. 
The recordings will be transferred onto an encrypted laptop and transcribed by the 
researcher. The encrypted laptop will held in a locked cabinet, at the University of 
Glasgow. The recordings will be backed-up and saved on a password protected part of 
the University of Glasgow network, only accessible to the principle researcher. All 
potential identifiers of persons or places will be anonymised. Data will be stored in 
accordance with University and NHS guidelines.  
Health and Safety issues 
Researcher safety issues  
All interviews will be conducted within the working hours of each service/clinic. The 
interviews will only be conducted while other staff members are on site. Regular 
supervision meetings will be arranged with the research supervisors to coincide with 
interviews. 
Participant safety issues  
Consultation with potential participants’ referrer (e.g. HF nurse) will allow for 
discussion regarding risk and safety issues. Potential participants will be given an 
information sheet prior to opting in to the study. Written consent will be obtained 
before the interviews and participants will be made aware (documented in information 
sheet, written consent form and explained verbally before the interview begins) that 
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they can opt out at any time. They will be made aware that they have the option to 
bring someone they know along to the interview. 
It may be difficult for participants to discuss their illness and difficulties associated 
with managing their illness. There may also be comorbid mood issues as research has 
shown that approximately 48% of patients with HF experience clinically significant 
levels of depressive symptoms (Dekker et al, 2009). Therefore, participants will be 
made aware of the focus of the interview and explained to them that some of the 
questions may be difficult for them. They will be made aware that they can stop at any 
time if they feel they do not want to continue with the interview and the researcher 
will regularly check-in with the participants to ensure that they are happy to continue 
with the interview. If a participant does become upset, the interviewer will stop, 
apologise for causing distress and allow participant to decide what they would like to 
do, i.e. continue, take a break or end the interview.  
Ethical issues 
Ethical issues to be considered are in relation to the potential distress associated with 
taking part in the study. This will be considered by the research team and in 
consultation with the referrer (e.g. HF nurse who knows the person). Every effort will 
be made to ensure that participants are aware of what is expected of them and what is 
involved in taking part. They will be reminded that they can opt out of the interview 
at any point with no consequence for themselves.  
The project will be submitted to NHS R&D management for approval. 
Ethical approval will be obtained from the East of Scotland Research Ethics Service.  
Financial issues 
Equipment costs will amount to one digital voice recorder (to be borrowed from the 
University of Glasgow), travel costs for participants to attend a clinic that is most 
convenient to them, and photocopying costs. 
Timetable 
Timetable agreed by the University of Glasgow: 
5
th
 December 2016: Draft of the proposal to be submitted to academic supervisors. 
30
th
 January 2017: Proposal submission to the university. 
28
th
 February 2017: Final approval of MRP proposal and associated paperwork. 
31
st
 March 2017: Ethical applications to be made. 
23
rd
 October 2017: Interviews to commence. 
24
th
 February 2018: Interviews to be concluded.  
 
The research will be written up into a thesis in the University of Glasgow and 
published into Clinical Psychology Journals. All publications will be anonymous, and 
no participant will be identifiable from their stories. Each participant will receive a 
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copy of the findings. It is hoped that the findings will be presented at conferences 
also.  
 
Practical Applications 
Understanding the experiences, difficulties and barriers to adherence by patients with 
a severe and enduring mental health problem and heart failure will help guide health 
care staff to develop appropriate interventions/treatment plans to best support patients.  
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